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Abstract
This work presents a wearable heart monitor at the ear that uses the ballistocardio-
gram (BCG) and the electrocardiogram (ECG) to extract heart rate, stroke volume,
and pre-ejection period (PEP) for the application of continuous heart monitoring.
Being a natural anchoring point, the ear is demonstrated as a viable location for
the integrated sensing of physiological signals. The source of periodic head movements
is identified as a type of BCG, which is measured using an accelerometer. The head
BCG's principal peaks (J-waves) are synchronized to heartbeats. Ensemble averaging
is used to obtain consistent J-wave amplitudes, which are related to stroke volume.
The ECG is sensed locally near the ear using a single-lead configuration. When the
BCG and the ECG are used together, an electromechanical duration called the RJ
interval can be obtained. Because both head BCG and ECG have low signal-to-noise
ratios, cross-correlation is used to statistically extract the RJ interval.
The ear-worn device is wirelessly connected to a computer for real time data
recording. A clinical test involving hemodynamic maneuvers is performed on 13
subjects. The results demonstrate a linear relationship between the J-wave amplitude
and stroke volume, and a linear relationship between the RJ interval and PEP.
While the clinical device uses commercial components, a custom integrated circuit
for ECG heartbeat detection is designed with the goal of reducing power consumption
and device size. With 58nW of power consumption, the ECG circuit replaces the tra-
ditional instrumentation amplifier, analog-to-digital converter, and signal processor
with a single chip solution. The circuit demonstrates a topology that takes advantage
of the ECG's characteristics to extract R-wave timings at the chest and the ear in
the presence of baseline drift, muscle artifact, and signal clipping.
Thesis Supervisor: Charles G. Sodini
Title: LeBel Professor of Electrical Engineering
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Chapter 1
Introduction
1.1 Cardiovascular Disease Monitoring
Cardiovascular disease (CVD) affects 37% of the United States population and is
the leading cause of death in the U.S. [1]. This work focuses on the continuous and
wearable measurements of key cardiovascular parameters including heart rate, stroke
volume (SV), and pre-ejection period (PEP). Each parameter has specific applications
in the field of cardiovascular disease monitoring.
Heart rate is obtained by measuring R-wave (the principal peak of the ECG) tim-
ings, which can be used to monitor arrhythmias that contain irregular beat intervals.
An example is atrial fibrillation (AF), which is the most common form of cardiac
arrhythmia [2]. AF is often undiagnosed, but increases the risk of stroke and heart
failure [2]. One of the markers of AF is irregular RR intervals (the time period be-
tween adjacent R-waves), which can be identified with continuous R-wave monitoring.
Another example is premature ventricular contraction (PVC). A PVC occurs when a
premature ventricular beat occurs before a regular beat, resulting in a large and wide
R-wave and a short RR interval. PVC's can occur in a healthy person, but they can
also be the symptom of an underlying CVD such as cardiomyopathy. PVC's irregular
RR intervals can be identified with continuous R-wave monitoring.
SV and PEP are important parameters for congestive heart failure (CHF) pa-
tients. In CHF, the heart is unable to pump sufficient blood to meet the body's
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metabolic demands. CHF accounted for 35% of all U.S. CVD deaths and was men-
tioned in one in nine death certificates in 2008 [3). SV is the volume of blood pumped
per heartbeat and is a measure of the heart's pumping ability. When SV is multi-
plied with heart rate, cardiac output (CO) can be obtained, which is defined as the
total volume of blood pumped per minute. Because of the heart's reduced pumping
ability, CHF patients exhibit decreased CO [4]. PEP can also be used to evaluate
ventricular performance in CHF patients [5] [6]. PEP is the delay between the ven-
tricular depolarization and the ejection of blood into the aorta. CHF patients have
been found to have the inability to decrease PEP upon cardiovascular demand, and
are characterized with prolonged PEP [4]. A continuous monitoring device for SV,
CO, and PEP can assist closed-loop managements of CHF in an outpatient setting,
where the device can detect trends and alarm caregivers or physicians to intervene
before the condition deteriorates to require hospitalization [7].
With the additional measurement of the photoplethysmogram (PPG), this work
also enables the continuous measurement of pulse transit time (PTT). PTT can be
used to cufflessly measure blood pressure. Hypertension is a chronic condition where
blood pressure is consistently above 140mmHg/90mmHg [8]. Hypertension increases
the risk for stroke, coronary heart disease, CHF, and renal disease [9]. Hypertension
affects one in three U.S. adults and the lifetime risk above the age of 40 is 90% [8].
Blood pressure can vary up to 20% in 24 hours due to circadian rhythms [10]. This
variation introduces fluctuations into spot measurements provided by traditional at-
home cuffed oscillometric monitors. In the clinic, "white-coat" and "masked" hyper-
tension can lead to misdiagnosis of hypertension [11]. A continuous and wearable
blood pressure monitor can detect changes in blood pressure throughout the day and
provide long term trends for lifestyle or medication adjustments.
1.2 The Ear as a Location of Heart Monitoring
While most wearable heart monitors are located on the chest, this work proposes the
site behind the ear as a measurement location (Figure 1-1). Inspired by hearing aids
19
and headsets, the ear location is advantageous for both physiological and mechanical
reasons.
Figure 1-1: The site behind the ear is proposed as a location for the wearable heart
monitor.
Physiologically, several signals can be measured at the ear location. These signals
include a mechanical signal (the ballistocardiogram, BCG), an electrical signal (the
electrocardiogram, ECG), and an optical signal (the photoplethysmogram, PPG).
These signals allow the measurements of heart rate, stroke volume, PEP, and PTT.
Mechanically, the mastoid area behind the ear is rigid, which reduces motion
artifacts compared to peripheral locations such as the earlobe, finger, and wrist. The
ear location is discreet because a small device can be concealed by the ear or hair.
Furthermore, as shown by hearing aids and Bluetooth headsets, the ear acts as a
natural anchor. This allows device attachment using an earbud instead of adhesives,
which cause skin irritation and require re-applications. For cuffless blood pressure
calculations, the ear remains in the same vertical orientation relative to the heart
when upright or sitting. This reduces the need for continuous hydrostatic pressure
calibrations [12].
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1.3 Aims of Thesis Work
The research presented in this thesis has the following seven aims:
" To achieve BCG measurements at the head with an ear-worn device in a clinical
setting.
" To characterize the head BCG across different subjects to compare its morpho-
logical similarities to the traditional BCG.
" To measure heart rate and respiratory rate from the head BCG and to compare
them with reference measurements.
" To investigate the relationship between the head BCG amplitudes and stroke
volume across different subjects.
. To achieve ECG measurements at the head with an ear-worn device in a clinical
setting.
" To use the head BCG and the head ECG to extract the RJ interval and to
investigate its correlation with pre-ejection period (PEP) across different sub-
jects.
" To create an ECG application-specific integrated circuit (ASIC) that can extract
R-wave timings from both chest and head ECG while being tolerant of signal
interferers, with the goal of minimizing power consumption to reduce battery
size and hence device size.
1.4 Thesis Organization
This thesis is organized into the following chapters:
e Chapter 2 introduces the physiological origins of the BCG. Measurement modal-
ities ranging from historical apparatus to modern methods are examined. Peri-
odic head motions are identified as a type of BCG. Two methods are presented
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for sensing the BCG at the head using capacitive electrodes and an accelerom-
eter. Each of the two methods has different hardware designs and challenges.
The head BCG's morphology and frequency content are examined along with
BCG measurements in different axes and postures. Methods to extract stroke
volume and respiratory rate are proposed.
" Chapter 3 begins with a background on traditional and modern chest ECG
measurements. Then, this chapter demonstrates that the ECG can be measured
at the head near the ear. The head ECG's morphology and frequency content
are compared with the chest ECG. The importance of the head ECG lies in the
R-wave timing, which is used in Chapter 4 to obtain heart intervals.
" Chapter 4 defines several important heart intervals, the first being PEP. After
discussing current PEP measurement methods, it is proposed that the RJ inter-
val can be used to estimate PEP. The RJ interval is a timing interval between the
ECG's R-wave and the BCG's J-wave and can be extracted statistically in the
presence of noise. Then, the PPG is introduced to define another heart interval
called pulse arrival time (PAT). The timing difference between PAT and PEP
defines a third time interval, PTT. PTT's importance lies in its relationship
with blood pressure. This relationship is derived using fluid dynamics.
" Chapter 5 describes the clinical prototype of the wearable heart monitor that
measures the BCG and the ECG. The device's hardware, firmware, and soft-
ware are discussed. A clinical test is conducted at MIT using the wearable heart
monitor and reference measurement equipment. The data allows the character-
ization of the head BCG morphology across different subjects. Using the data,
the device's measurements of heart rate, stroke volume, and PEP are evaluated.
" Chapter 6 presents a nanowatt ECG ASIC that extracts heartbeats and R-wave
timings. The goal of the ECG ASIC is to directly replace the discrete ECG cir-
cuit components in the wearable heart monitor while consuming significantly
less power and area. This goal is realized with a new circuit topology that re-
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moves the need for an analog-to-digital converter and a signal processor while
being tolerant to signal interferers. The low power circuit design of each cir-
cuit block, the electrical characterization, and ECG measurements results are
discussed.
* Finally, Chapter 7 concludes the work with a summary of contributions and
items for future work.
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Chapter 2
The Ballistocardiogram (BCG)
This chapter introduces the physiological origins of the ballistocardiogram (BCG) and
provides a background on the traditional and modern BCG measurement methods. A
new BCG measurement method is proposed that senses the BCG signal at the head.
The head BCG is measured using two methods, one of which uses accelerometry and
is chosen as the method to study. Using acceleration measurements, the head BCG
is characterized in terms of morphology, frequency content, and physical orientation.
Then, methods to extract respiratory rate and stroke volume are proposed.
2.1 The Traditional and Modern BCG
The BCG is a non-invasive measurement of the body's mechanical reaction to the
blood ejected by the heart during the cardiac cycle. Signals representing the BCG
were first published by Gordon in 1877, when he found that for a person "maintaining,
as far as possible, perfect stillness, ...a rhythmic movement ...synchronous with the
pulse" can be detected [13]. The first practical measurement method was invented by
Starr in 1939, who also coined the name "ballistocardiogram" [14]. Starr's setup has
the subject fixed to a mechanical table (Figure 2-3(a)) that is laterally spring loaded.
The force exerted by the body is recorded as the BCG.
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Figure 2-1: A standard BCG with its waves labeled (figure from [14]).
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Figure 2-2: Blood flow through the aorta with I-wave and J-wave occurrences labeled
(figure adapted from [15]).
A healthy subject's BCG is shown in Figure 2-1. A corresponding blood flow
diagram of the aorta is shown in Figure 2-2. I-wave and J-wave are of primary interest.
Wave I is due to the "headward" ejection of blood from the left ventricle into the aorta.
Due to Newton's Third Law of Motion, this causes the body to recoil "footward" [16].
Wave J is due to the movement of blood from the aorta towards the abdomen through
the descending aorta. This causes the body to recoil "headward" [16]. The residual
oscillations after the J-wave are due to damped mechanical vibrations in the body
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resulting from the IJ interval [14].
The early work demonstrates that the BCG morphology can offer insights into
stroke volume, the risk of heart attack, heart recovery after myocardial infarction, and
mortality [14] [17] [18]. However, due to the lack of standardization and the advent of
the echocardiogram, the BCG did not gain traction in the medical community [19].
Recently, there is a renewal of interest in the BCG in the scientific community [20].
This is mostly driven by modern technologies that have made the detection of the
BCG signal more accessible. Figure 2-3 shows the traditional method and the modern
methods. One method uses a strain-sensing foot scale to measure the BCG in an
upright posture (Figure 2-3(b)) [21] [22]. A second method uses chairs (Figure 2-
3(c)) that sense the BCG from electromechanical film sensors or pressure sensors for
non-ambulatory situations [23] [24] [25]. Beds (Figure 2-3(d)) with load cells, strain
gauges, and air mattress pressure sensors are also used to sense the BCG for bedridden
patients or subjects during sleep [26] [27].
All of the above methods involve a stationary measurement device that does not
allow continuous and portable measurements. The use of 3D accelerometry to mea-
sure the BCG in microgravity and dry immersion is explored by Migeotte et al. using
a chest strap equipped with accelerometers (Figure 2-3(e)) [28]. However, accelerom-
eters have yet to be studied for sensing the BCG in a normal gravity environment.
It should be noted that the traditional BCG records the force exerted by the body
instead of body acceleration. Therefore, accelerometer BCG readings can be con-
verted to traditional BCG readings by multiplying the acceleration by body mass
(Fbody - mboodabody).
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Figure 2-3: Traditional and modern BCG measurement methods: a) the traditional
Starr BCG table [14], b) the BCG foot scale [29], c) the BCG chair [23], d) the BCG
bed [26], and e) the 3D BCG chest strap [28].
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2.2 The Head BCG
The MRI society has been documenting ballistocardiographic head movements as a
source of movement artifacts in EEG measured during MRI [30] [31] [32]. Therefore, a
proxy measurement of the BCG at the head is a possibility. Because of fundamentally
different measurement techniques, the flexibility of the neck, and the lack of a low
friction movement axis, the morphology of the head BCG is expected to differ from
that of the traditional BCG.
It should be reinforced that the head BCG is due to the overall head acceleration
instead of the local skin pulsations near the ear. To verify this, an accelerometer is
mounted outside a rigid helmet that is worn on the head, where skin pulsations cannot
be detected. Figure 2-4 shows that the head BCG accelerations remain detectable
external to the helmet.
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Figure 2-4: Measured head BCG signals (headward-footward direction) from an ac-
celerometer mounted outside a rigid helmet worn on the head.
To further investigate the nature of the head BCG movement, a whole-body video
motion analysis is done in collaboration with Guha Balakrishnan (MIT). The videos
are recorded with 1920 x 1080 resolution at 29.97 frames per second amid a bitrate
of 91mbps. The motions of the head and the chest are tracked by an algorithm,
bandpass filtered from 1Hz to 5Hz, and then plotted versus time. The subject is
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standing upright with the coordinate system labeled in Figure 2-5. Both frontal and
sideways views are recorded.
Z
X
Figure 2-5:
labeled.
The subject as seen by the video camera. The coordinate system is
Figure 2-6 shows the y-axis motion versus time. It can be seen that both the
chest and the head contain pulsatile BCG motions. Furthermore, as shown by the
dotted lines aligned to the head motion's peaks, the head motion is synchronized to
the chest motion. This suggests that the head is moving coherently with the chest in
the y-axis.
Figure 2-7 shows the x-axis motion versus time, and Figure 2-8 shows the z-axis
motion versus time. The existence of the BCG signal in these two axes suggests that
the BCG motion is three dimensional even though the principal blood flow is vertical.
However, the misalignment of the chest motion's peaks to the head motion's peaks
in the x-axis suggests that the forward-backward motions are not as coherent as the
other two axes.
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Figure 2-6: The y-axis chest and head motion extracted from video. The head mo-
tion's peaks (dotted lines) coincide with the chest motion's peaks.
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Figure 2-7: The x-axis chest and head motion extracted from video. The head mo-
tion's peaks (dotted lines) are misaligned with the chest motion's peaks.
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Figure 2-8: The z-axis chest and head motion extracted from video. The head mo-
tion's peaks (dotted lines) coincide with the chest motion's peaks.
The above analysis suggests that the head BCG motion is potentially contributed
by the upper body's BCG movement. However, a component of the head BCG motion
can also be due to the carotid blood flow into the head, which causes the head to
bob vertically while pivoted at the neck. Both explanations are based on the same
fundamental BCG theory of mechanical recoil caused by the internal movement of
blood, whether it is in the aorta or in the carotid artery.
Two wearable head BCG measurement methods employing capacitive transduc-
tion and accelerometry are presented in the following sections.
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2.3 Head BCG Measurements using Hybrid Elec-
trodes
The first method for sensing the head BCG involves a hybrid electrode setup. This
setup consists of two capacitive electrodes for differential sensing, and one dry elec-
trode for common-mode feedback (CMFB). Because the capacitive electrodes' con-
tact to the skin is sensitive to motion, their capacitances change with the mechanical
movements associated with the head BCG, thus converting the mechanical activity
into electrical signals. To reduce electrical interference, the capacitive electrodes are
actively shielded. A dry electrode is used for CMFB to reduce powerline interference.
The dry electrode avoids skin irritation caused by gel electrodes and still maintains
a low resistance feedback path to the body.
The electrodes are constructed using nylon fabric as the insulator and conductive
nickel fabric as the conductor. Both fabric materials are suitable for comfortable long
term wear. Photos of the electrodes and their construction materials are shown in
Figure 2-9.
d~
Figure 2-9: A photo of a) the capacitive sensing electrode, b) the dry CMFB electrode,
c) the conductive fabric, and d) the nylon fabric.
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Figure 2-10 shows the cross-section of the electrodes placed on skin. The capacitive
sensing electrodes 1 and 2 have five layers consisting of a sensing layer, an active
shield layer, and three insulating layers. The dry CMFB electrode is located between
electrodes 1 and 2 and contains one layer driving the CMFB signal into the body and
one insulating layer.
Conductive Fabric
Nylon Fabric
Electrode 1 Electrode 2
(Capacitive) (Capacitive)
CMFB Electrode
(Dry)
Skin
Figure 2-10: A 3D cross-section of the hybrid electrode setup placed on skin, with
conductive and insulating layers shown.
The diagram of the discrete head BCG front-end circuit is shown in Figure 2-11.
The capacitive electrodes have a capacitance to skin of approximately 4pF, or 4GQ
of impedance at 10Hz. Therefore, to minimize signal loss due to voltage division, the
capacitive electrodes are connected to high impedance buffers with IBIAS = 10f A
and with 5GQ bias resistors. The buffers provide active shields for the electrodes,
which prevent capacitive coupling away from the skin. The differential signal goes
through two twin-T 60-Hz notch filters and into an instrumentation amplifier with a
gain of 40dB. The common-mode signal is negatively amplified by 46dB and then fed
back into the body to reduce powerline interference. After the output, the signal is
converted into the digital domain and then low pass filtered with a cutoff frequency
of 40Hz.
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Figure 2-11: The head BCG front-end circuit.
Using the hybrid electrodes and the front-end circuit, the head BCG is measured
behind the right ear and is plotted in Figure 2-12.
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Figure 2-12: The head BCG measured using hybrid electrodes.
The head BCG in Figure 2-12 has a different morphology compared to the tra-
ditional BCG (Figure 2-1). Unlike the low friction axis offered by a BCG table, the
headward-footward motion is now constrained by the ground. Also, the method of
measurement is capacitive instead of directly mechanical. However, the primary wave,
or J-wave, remains present.
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2.4 Head BCG Measurements using an Accelerom-
eter
Although the hybrid electrode setup can transduce the head BCG into electrical sig-
nals, it has the inherent disadvantage of requiring three electrodes. This becomes
impractical when considering that the electrocardiogram (ECG) requires two addi-
tional electrodes (Chapter 3) and the skin area near the ear is limited. The electrode
setup is also susceptible to powerline interference. Furthermore, the electrodes need
to maintain planar adhesion to the skin, leading to mechanical design issues and
possible skin irritation.
As an alternative, MEMS accelerometers are explored for sensing the head BCG.
The accelerometer's advantage is that it does not need electrodes, wires, or skin
contact, thus resulting in a more robust mechanical design. Also, the accelerometer
is immune to electrical interference. Additionally, the accelerometer provides wearer
orientation and activity information for contextual data analysis.
BCG Accelerometer
(a) (b)
Figure 2-13: a) The accelerometer-based BCG device worn at the ear, and b) the
device backside exposed to show the accelerometer.
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For testing, we use a 14-bit low noise (0.69mGrms at ±2G range) MEMS tri-axial
accelerometer (Bosch BMA180) that is mounted at the ear as shown in Figure 2-13.
The accelerometer is enclosed in the housing and occupies 3mm x 3mm x 1mm of
space. The acceleration data is wirelessly transmitted to a computer using a 2.4GHz
radio (Texas Instruments CC2500).
2.4.1 The Head BCG Morphology
The measured y-axis (headward-footward) head BCG in the upright standing posture
is shown in Figure 2-14.
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Figure 2-14: The head BCG measured
in the standing posture. The J-waves
by a y-axis (headward-footward)
are annotated.
accelerometer
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The J-waves in the head BCG are immediately visible as the principal peaks.
To examine the secondary BCG waves, the ensemble averages of the head BCG are
created by aligning each beat's J-wave and then averaging the beats. As shown in
Figure 2-15, with an increasing number of ensemble averages, H, I, K, and L-waves
from the traditional BCG become visible. The fact that the majority of the traditional
BCG waves exist in the head BCG suggests that the underlying accelerations are
preserved. The wave amplitudes are expected to differ between subjects and this
variation is characterized through the clinical test in Chapter 5.
The signal quality of the head BCG can be evaluated by its beat-to-beat morphol-
ogy's repeatability. A clean BCG with no artifacts typically has highly consistent beat
morphology, whereas motion artifacts will have uncorrelated beat-to-beat morphol-
ogy. To quantify the repeatability of the BCG signal, we introduce a metric that is
based on the standard deviation between individual beats to the ensemble average.
This standard deviation is normalized to the ensemble's J-wave amplitude to produce
a metric called Normalized Standard Deviation from the Ensemble (NSDE). NSDE
is defined in Equation (2.2), where M is the number of samples per beat, N is the
number of beats, Ensemble is the ensemble average of N beats, and J is the ensemble
average's J-wave amplitude. For the measurement in Figure 2-14, NSDE is 21% for
N = 20. While a greater N reduces fluctuations in the ensemble waveform, it also
masks any short term changes due to averaging. N = 20 is chosen for the ensemble
averages in this work as it produces sufficiently stable ensemble waveforms with an
averaging window of approximately 20 seconds.
def 11NSDE ( (Stdev (Beati - Ensemble)) (2.1)
N M
-
(E f (Beat [j] - Ensemble[ j])2 (2.2)
=1 j=1
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Figure 2-15: a) The head BCG from the first beat, and the ensemble head BCG's
from b) the first 4 beats, c) the first 16 beats, d) the first 64 beats, e) the first 80
beats, and f) the traditional BCG [14]. The underlying individual BCG waveforms
are shown in grey. The subject's average beat-to-beat interval is 0.73s.
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2.4.2 The Head BCG Frequency Range
Figure 2-16 shows the head BCG's power spectral density of a sample head BCG mea-
sured over 60 seconds (Welch's method with 190Hz sampling frequency, 48s hamming
window, 24s overlap, and 6064-point FFT). 89% of the total signal power resides in
the range of 1Hz - 10Hz. This is consistent with the previous BCG work, which
states that the majority of the BCG's frequency content is less than 10Hz [33] [34].
For subsequent head BCG measurements, the signal is bandpass filtered in the range
of 1Hz - 10Hz to remove DC gravity, sub-Hz baseline drift caused by respiration,
and movement artifacts above 10Hz.
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Figure 2-16: The power spectral density of a sample head BCG.
2.4.3 The Head BCG in Different Axes and Postures
Figure 2-17 shows that the head BCG in the upright standing posture exists in all
three axes. However, the y-axis is the dominant BCG axis because blood volume
movement is mainly in the y-axis.
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Figure 2-17: Measured tri-axial head BCG in the standing posture
annotated in the y-axis data.
with J-waves
To demonstrate that the head BCG can be measured in different postures, Fig-
ure 2-18 shows the y-axis (headward-footward) measurements in standing, sitting,
and supine postures. The y-axis is the dominant axis of the head BCG in all three
positions. However, in the supine position, the higher frequency accelerations are
dampened by static friction with the stationary table.
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Figure 2-18: Measured y-axis head BCG in various postures with J-waves annotated.
2.4.4 The Head BCG and Stroke Volume
In Starr's pioneering work, it is mentioned that the BCG amplitude is directly related
to stroke volume [14]. Physically, the movement of a larger blood mass leads to a
more pronounced recoil and a higher BCG amplitude. This direct relationship is
investigated using the clinical results in Chapter 5.
It should be noted that if both heart rate and SV are obtained, then cardiac output
(CO) can be calculated. CO is the total volume of blood pumped by the heart per
minute and is defined as the product of heart rate and SV (CO[L/min] = HR x SV).
CO is an important parameter of cardiac condition especially in diseases such as
congestive heart failure [4].
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2.4.5 Head BCG Derived Respiration
Lastly, since breathing induces physical movement, the accelerometer's baseline is
modulated by respiration. In Figure 2-19, the low frequency (0.05Hz - 0.7Hz) base-
line of the accelerometer y-axis signal is plotted with a simultaneous respiration mea-
surement from a chest band with a strain sensor. The BCG baseline's peaks do not
coincide with the chest band's peaks because the BCG signal measures y-axis accel-
eration while the chest band measures radial strain. However, the BCG baseline can
produce the same respiratory rate (breaths/min) as the chest band.
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Figure 2-19: The head BCG
ration signal simultaneously
baseline (bandpass filtered 0.05Hz -
measured by a chest band.
0.7Hz) and respi-
2.4.6 Concluding Remarks
Because the head BCG is in the range of 10mG,,, it can only be measured in states
of relative rest. For example, walking generates excessive acceleration of hundreds of
mG's that are in the same frequency range as the head BCG, thus effectively masking
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the BCG signal. However, for the target application of long term wearable monitoring,
it is possible to form trends from measurements throughout the day when the wearer
is relatively still. Di Rienzo et al. have studied the frequency of at-rest (less than
4mG) time segments from wearable accelerometers [35). For example, in Figure 2-20,
one can expect the subject to be still for an average of 40 20s time segments per hour
during the day.
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Figure 2-20: Number of at-rest segments during day and night versus segment length
for five subjects. Each subject is color-coded. (figure from [35]).
By itself, the head BCG can be used for heart rate, stroke volume, and respiratory
rate measurements in states of rest without the use of electrodes or adhesives. It will
be shown in Chapter 4 that when BCG and ECG timings are combined, electrome-
chanical timings can be obtained that relate to the heart's muscle function.
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Chapter 3
The Electrocardiogram (ECG)
This chapter provides a background on the traditional chest electrocardiogram (ECG)
and its origins. Then, the measurement of the ECG at the head is demonstrated.
The head ECG's morphology is compared to that of the chest ECG using ensemble
averaging as a tool. Lastly, the head ECG's frequency spectrum is compared with
the chest ECG's spectrum in terms of fundamental and harmonic frequencies.
3.1 The Chest ECG
The ECG is a non-invasive surface measurement of the electrical potentials of the
heart. Augustus Waller published the first human ECG using a capillary electrometer
in 1887 [36]. In 1902, Willem Einthoven demonstrated the galvanometric measure-
ment of the ECG from limbs dipped in saline solutions and began the use of the ECG
as a clinical tool [37]. Using the morphologies and rhythms of different ECG vectors,
the ECG is used to diagnose diseases in specific regions of the heart and has become
a primary tool for the non-invasive assessment of cardiac health.
Modern measurements of the ECG use gel electrodes usually made of AgCl for
its low half-cell potential. The ECG signals are usually on the order of 1mV and are
amplified using low noise instrumentation amplifiers. Figure 3-1 shows the anatomy
of the heart while Figure 3-2 shows a modern lead II chest ECG with different waves
labeled.
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Figure 3-1: The anatomy of the heart (figure from [38]).
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Figure 3-2: A standard lead II chest ECG with its waves labeled (measured by the
ECG ASIC from Chapter 6).
In Figure 3-2, the P-wave signifies the depolarization of the atria, the QRS complex
signifies the depolarization of the ventricles, and the T-wave signifies the repolariza-
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tion of the ventricles.
Each differential vector measurement of the ECG is known as a "lead." The stan-
dard clinical ECG measurement uses 12 leads which are shown in Figure 3-3. Six of
the leads in the plane of the body are called frontal leads. The remaining six leads
(V1-V6) are pre-cordial leads perpendicular to the body.
aVR aVL
SV6 Lead I
Lead III aVF Lead i
Figure 3-3: The standard 12-lead ECG (figure from [39]).
For diagnosis or monitoring purposes, it is valuable to record long term ECG
during the patient's daily activities. Such a device is known as a Holter monitor,
which measures one or more leads of the ECG on the chest and stores the data
for analysis. Holter monitors have progressed from tape recorders to small solid state
devices as shown in Figure 3-4. However, because the highest signal quality is desired,
all such ECG monitors are located on the chest.
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Figure 3-4: Traditional and modern Holter monitors: a) the traditional Holter mon-
itor [40], b) the Mindray Netguard [41], c) the Intelesens V-Patch [42], and d) the
Corventis NUVANT [43].
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3.2 The Head ECG
3.2.1 Head ECG Measurements
Because the body is a conductive medium, an ECG signal from the heart can be
detected elsewhere on the body in an attenuated form. To avoid ECG wires from the
ear-worn heart monitor to the chest, the ECG is measured locally near the ear. One
electrode is placed on the mastoid area, and the second electrode is placed on the
upper middle neck. The mastoid's bony structure and the neck's flat surface allow a
stable electrode contact. Together, the two electrodes measure a single-lead ECG.
Usually, a third driven-right-leg (DRL) electrode is used for common-mode feed-
back (CMFB). This DRL electrode aims to reduce common-mode powerline interfer-
ence and to set the circuit's DC potential to the body's potential. However, because
of the limited skin area near the ear, this DRL electrode is omitted. This decision
leads to certain circuit design considerations as discussed below.
The ECG front-end circuit is shown in Figure 3-5.
1pF
Electrode 1
1MO IA Anti-alias 12-bit ADC Digital
Filter F= 155Hz Output
Electrode 2
1pF
Figure 3-5: The head ECG front-end circuit.
The two differential electrodes go through a high pass filter with a corner frequency
of 0.16Hz. This high pass filter is necessary to isolate the DC voltage of the body
(due to the absence of the DRL electrode) and to remove the near-DC electrode offset
voltage (EOV) at the electrode-skin interface.
The filtered differential signal is amplified by an instrumentation amplifier (IA).
The IA gain is adjustable to account for ECG amplitude variations across subjects.
Because the ECG amplitude near the ear is in the range of 3 0pV,, the IA's noise
performance is important. The selected IA (TI INA333) has an input-referred noise
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that is comparable to the thermal noise generated by the 1MQ biasing resistors within
a bandwidth of 78Hz (1.1pVrms).
The amplifier output is low pass filtered at 117Hz to prevent the aliasing of out
of band noise. Then, the signal is digitized by a 12-bit SAR ADC at a sampling
frequency of 155Hz. This sampling frequency is determined by the radio bandwidth
for real time transmission. Because there is no DRL electrode, powerline interference
is removed by digital filters after the ECG front-end.
Using clinical AgCl electrodes, Figure 3-6 shows ECG measurements taken from
the chest (lead II, 15cm apart, gain of 250) and from the left mastoid area (4cm apart,
gain of 7,000).
Chest ECG (Gain = 250)
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Figure 3-6: a) The ECG measured from the chest, and b) the ECG measured from the
mastoid area behind the left ear. The ECG's are filtered with a 1 - 50Hz bandpass
filter. Measurements are not simultaneous.
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As seen in Figure 3-6, the ECG measured at the mastoid area is in the range of
30pVp - 40pjV,, which is two orders of magnitude smaller than the standard chest
ECG. This attenuation is due to the pattern of the ECG field lines at the head, which
yield a very small potential difference when projected onto the mastoid lead. Because
of this attenuation, the head ECG has a poor signal-to-noise ratio and only R-waves
are immediately visible.
3.2.2 The Head ECG Morphology
Figure 3-7 shows a longer duration of the head ECG used for ensemble averaging.
0.2
0.1
CD0
W
CU
I ~~~[" I'! ~~II ''" 1''''
Figure 3-7: The head ECG measured over 78 seconds.
To examine the secondary ECG waves, the ensemble averages of the head ECG
are created by aligning each beat's R-wave and then averaging the beats. As shown
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in Figure 3-8, with an increasing number of ensemble averages, P, Q, S, and T-waves
become visible. For reference, Figure 3-8(f) shows an ensemble Lead II chest ECG
measured from the same subject under the same heart rate immediately following the
head ECG measurements. One can observe that the head ECG's wave timings are
representative of the chest ECG's wave timings. This demonstrates that the mastoid-
neck ECG lead can provide the standard ECG waves when ensemble averaging is used
to remove uncorrelated signal fluctuations.
3.2.3 The Head ECG Frequency Content
Figure 3-9 plots the power spectral density (Welch's method with 190Hz sampling
frequency, 8s hamming window, 4s overlap, and 6032-point FFT) of 78 seconds of
the head ECG and the chest ECG from the same subject under the same average
beat-to-beat interval of 0.75s, which corresponds to 1.3Hz of beat-to-beat frequency.
While the chest ECG's peak power content is at 1.3Hz, the head ECG's 1.3Hz peak
is submerged below the significant "noise" below 4Hz. Because the ECG amplifier is
chopper modulated at the inputs, its 1/f noise is suppressed and the amplifier input
noise from 0.1Hz to 10Hz is only 1pVp, (the head ECG is approximately 30pu14).
Therefore, the sub-4Hz content in the head ECG arises from either motion artifacts
or muscle signals (electromyography).
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Figure 3-8: a) The head ECG from the first beat, and the ensemble head ECG's from
b) the first 4 beats, c) the first 16 beats, d) the first 64 beats, e) the first 99 beats,
and f) the ensemble Lead II chest ECG from the same subject under the same heart
rate. The underlying individual ECG waveforms are shown in grey. The subject's
average beat-to-beat interval is 0.75s.
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Figure 3-9: a) The power spectral density of the head ECG, and b) the power spectral
density of the chest ECG from the same subject. The subject's average beat-to-beat
frequency is 1.3Hz.
The harmonics of the 1.3Hz fundamental beat-to-beat frequency can be seen
throughout the chest ECG, but only appear intermittently in the head ECG. This is
because the head ECG's morphology is not as repeatable as that of the chest ECG,
thus reducing signal periodicity and harmonics.
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3.2.4 Concluding Remarks
The value of the head ECG to the wearable heart monitor is in the R-wave timings.
Just like the BCG's J-waves, the R-waves can be used to measure heart rate. This
redundancy can be used to detect errors in heart rate data. Chapter 4 explains how
the R-waves can be used in conjunction with the J-waves to derive the heart's pre-
ejection period. A statistical method to extract this heart interval from low quality
signals will be discussed in Section 4.1.1. A low power integrated circuit that can
extract R-wave timings from the head ECG will be presented in Chapter 6.
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Chapter 4
Heart Intervals
This chapter begins with the definition of pre-ejection period (PEP) and a discussion
of the current non-invasive PEP measurement methods. Through timing diagrams,
PEP is shown to relate to a delay interval between the ECG and the BCG called
the RJ interval. A statistical method to extract the RJ interval from the ECG and
the BCG is presented. Then, the photoplethysmogram (PPG) is introduced to define
another interval called pulse arrival time (PAT). With PEP and PAT, pulse transit
time (PTT) can be obtained. The value of PTT is in its relationship with blood
pressure, which is derived based on fluid dynamics.
4.1 Pre-ejection Period (PEP)
PEP is defined as the time period from the beginning of the ECG's Q-wave, which
marks the beginning of the ventricular depolarization, to the opening of the aortic
valve, which marks the ejection of blood into the aorta [16].
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Figure 4-1: A Wiggers diagram showing the definition of PEP in the context of
pressure waveforms, the ECG, and the RJ interval (figure adapted from [44]).
PEP is denoted by the period between time markers A and C in Figure 4-1.
PEP is the sum of two components: electromechanical delay (EMD) and isovolumic
contraction time (ICT). EMD (AB interval in Figure 4-1) is the time needed for
the electrical stimulus to activate the ventricular heart muscles. Following EMD,
left ventricular pressure increases until it reaches the aortic pressure. This period
is ICT (BC interval in Figure 4-1). After ICT, the equalization of ventricular and
aortic pressure opens the aortic valve and ventricular ejection occurs. This interval is
marked by the CD interval in Figure 4-1 and is known as the left ventricular ejection
time (LVET). It should be noted that the ratio of PEP to LVET (PEP/LVET) has
an inverse relationship with stroke volume (SV), which is the volume of blood ejected
per beat and correlates with cardiac function [16].
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During ICT, the maximum rate of left ventricular pressure increase (max(dP/dt))
is a measure of contractility, which is the intrinsic ability of the heart muscle to
produce force [16]. While EMD is relatively constant, ICT is highly variable be-
cause contractility changes under different sympathetic responses and cardiac dis-
eases [45] [46] [47]. Therefore, PEP is inversely related to contractility (given a
constant cardiac afterload). As a result, PEP can be used to determine left ventricu-
lar performance in patients with cardiovascular disease such as cardiomyopathy and
abnormal left ventricular contractions [5] [6].
There are several non-invasive methods to measure PEP. The impedance cardio-
gram (ICG) is widely used in conjunction with the ECG as a non-invasive method to
measure PEP. The ICG uses thoracic impedance (Z), which is measured by apply-
ing a continuous AC current through the chest and sensing the resulting AC voltage
(Z = V/I). The ICG current flows through the aorta, which provides a path of least
resistance due to its blood volume. The time derivative of impedance (dZ/dt) is the
ICG signal [48].
Figure 4-2 shows simultaneously measured ECG, the absolute change of thoracic
impedance from baseline (AZ), and ICG (dZ/dt). During PEP, there is minimal
blood volume in the aorta, which sets the baseline impedance. At the end of PEP,
the opening of the aortic valve causes an increase in aortic blood volume and a
decrease in impedance (conventionally marked by an increase in AZ in literature),
which leads to a beginning of incline in the ICG marked by the B-wave. After the
blood has been ejected from the left ventricle, the aortic valve closes and causes a
drop in aortic blood volume and an increase in impedance (conventionally marked
by a decrease in AZ). This is marked by a local minimum in the ICG known as the
X-wave. Therefore, PEP can be measured by the delay between the ECG's Q-wave
and the ICG's B-wave. The interval between the ICG's B-wave and X-wave is LVET.
Using both PEP and LVET, the ICG can calculate SV.
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Figure 4-2: Simultaneous ECG, thoracic impedance, and ICG measured by the BioZ
ICG machine on a subject.
Another method to measure PEP is to use echocardiography with the ECG.
Echocardiography uses ultrasound to determine blood flow in the heart. Therefore,
by measuring the delay from the ECG's Q-wave to the left ventricular ejection, PEP
can be obtained. An echocardiogram with the ECG is shown in Figure 4-3, where
PEP and LVET are denoted.
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Figure 4-3: Simultaneous ECG and aorta echocardiogram with PEP and LVET shown
(figure from (49]).
In all methods mentioned above, the PEP measurement requires a large stationary
apparatus and in the case of echocardiography, a trained operator. Currently, no
portable measurement method of PEP exists.
4.1.1 Estimating the PEP using the RJ interval
When combined, the BCG and the ECG can be used to extract the RJ interval.
The RJ interval is defined as the interval between the ECG's R-wave and the BCG's
J-wave. In terms of cardiac events, the RJ interval is the delay between the left
ventricular depolarization and when the ejected blood reaches maximum acceleration
in a major artery such as the descending aorta [22] [45] [46].
Figure 4-4 shows the RJ interval denoted on simultaneously measured head ECG
and head BCG. As shown in Figure 4-1, the RJ interval includes ICT and an offset.
Because PEP also consists of ICT and an offset (EMD), the RJ interval is linearly
related to PEP. From previous work, linearity is indeed observed between the RJ
interval and PEP from foot scale measurements of BCG [451.
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Extracting the RJ interval using Cross-correlation
To measure the RJ interval, the simplest method is to use a peak detection algorithm
to determine the delay between the ECG's R-wave and the BCG's J-wave. However,
as shown in Figure 4-4, the BCG and ECG signals at the head have low amplitudes
in the respective ranges of 1OmGp, and 30pV,, thus leading to low signal-to-noise
ratios where a peak detection algorithm would be prone to error.
Instead, cross-correlation is proposed as a statistical method for determining the
RJ interval. Cross-correlation between two real signals is defined in Equation (4.1),
where the cross-correlation at a particular time is the dot product of the first signal
and a time-shifted version of the second signal. Maximum cross-correlation occurs
when the shape of the time-shifted version of the second signal most closely resembles
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This method takes advantage of the fact that both head BCG and head ECG
waveforms have a similar morphology and are phase-locked to a lag index equal to
the RJ interval. Instead of relying on peak detection of individual beats, this method's
noise tolerance is provided by statistical information from multiple beats.
To demonstrate this, Figure 4-5 shows a time window of head ECG signal cross-
correlated with a simultaneous head BCG signal. The highest peak of the cross-
correlation result occurs when the R-wave of the ECG and the J-wave of the BCG co-
incide during time-shifting. As expected, the lag index of the highest cross-correlation
peak is the RJ interval.
To reduce the amount of computation, cross-correlation can be limited to a lag
range of 0.1s to 0.3s because the RJ interval is physiologically within this range [21].
This range is shown as the shaded region in Figure 4-5(b). For example, if the time
window is 8s long, then this 0.2s truncation allows a 97.5% computational saving
compared to a complete cross-correlation. Another benefit to this truncation is that
it removes nearby cross-correlation peaks from consideration, thus improving peak
confidence.
Additional cross-correlation peak confidence can be achieved by lengthening the
time windows of the BCG and ECG signals. This uses more R-waves and J-waves
to calculate the correct correlation at the cost of smoothing higher frequency fea-
tures of the R.J interval and increasing the amount of computation. To quantify the
cross-correlation peak confidence versus time window length, we use the ratio of the
highest cross-correlation peak (within 0.1s - 0.3s) magnitude to its adjacent peak
(with positive lag) magnitude (see circled peaks in Figure 4-5(b)). A higher ratio
means greater confidence that the highest cross-correlation peak corresponds to the
RJ interval. Figure 4-6 plots this ratio versus time window length for a sample data
segment.
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Figure 4-5: a) Simultaneous time windows of the head ECG and the head BCG, and
b) the cross-correlation result showing that the highest peak's lag index is the RJ
interval. The highest peak and the adjacent peak (with positive lag) are circled in
blue.
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Figure 4-6: The ratio of the highest cross-correlation peak (within 0.1s - 0.3s)
magnitude to its adjacent peak (with positive lag) magnitude, plotted versus cross-
correlation window length.
In Figure 4-6, it can be seen that after the window length reaches 6s, a point
of diminishing return is reached where additional signals are sufficiently similar that
there is no improvement in cross-correlation peak confidence. In the clinical test in
Chapter 5, a window length of 8s is chosen to reliably extract the RJ intervals from
measured ECG and BCG data.
4.2 Pulse Arrival Time (PAT)
The photoplethysmogram (PPG) is an optical volumetric measurement of blood by
sensing changes in light absorption. The PPG is usually obtained with a pulse oxime-
ter (Figure 4-7), which measures optical transmission at the finger to determine heart
rate and peripheral oxygen saturation (SpO 2 ). The mastoid area behind the ear
contains bony structures that allow reflectance PPG to be measured. Figure 4-8
demonstrates that simultaneously measured reflectance ear PPG and transmittance
finger PPG have the same underlying morphology, which consists of a principal peak
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signifying the arrival of the pulse wave, and a secondary peak signifying the reflected
pulse wave. The work on PPG measurements is being done by Eric Winokur.
j
=
Figure 4-7: A finger clip pulse oximeter uses the PPG to measure heart rate and
blood oxygenation (figure from [50]).
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Figure 4-8: Simultaneously measured reflectance ear PPG and transmittance finger
PPG showing the principal and reflected waves.
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Pulse arrival time (PAT) is defined as the delay between the ECG's Q-wave and
the point of the PPG's maximum positive slope. This is illustrated in Figure 4-9. It
is worth noting that most current work uses the ECG's R-wave instead of Q-wave
due to R-wave's ease of detection [51] [52].
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Figure 4-9: Pulse arrival time (PAT) is defined
Q-wave and the PPG's maximum increase.
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as the interval between the ECG's
Physiologically, PAT signifies the entire interval from the beginning of the heart's
depolarization to the arrival of the blood pulse wave at a peripheral location. PAT's
usefulness arises from its relation with PEP and pulse transit time (PTT), as will be
explained in the next section.
4.3 Pulse Transit Time (PTT)
PTT is defined as the time interval for a blood pulse wave to travel between two
locations in the artery. Figure 4-10 shows the chronological order of cardiac timings
starting with the ECG's Q-wave, which is the beginning of ventricular depolarization.
Q-wave also marks the beginning of PEP, during which the heart builds its internal
pressure to eject blood. The opening of the aortic valve marks the end of PEP.
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At this moment, the blood pulse wave starts its transit to the peripherals and PTT
begins. At the peripherals, the point of the PPG's maximum positive slope marks the
local arrival of the pulse wave, or the end of PTT. The entire duration between the
ECG's Q-wave and the point of the PPG's maximum positive slope is PAT. Therefore,
PAT = PEP + PTT [51] [52].
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Figure 4-10: The relationship between PAT, PEP, and PTT.
Since PAT can be measured using the ECG and the PPG, and PEP can be esti-
mated by measuring the RJ interval between the ECG and the BCG, then PTT can
be estimated using the ECG, BCG, and PPG. In fact, only the BCG and the PPG
are needed for PTT. This is because the delay between the BCG's J-wave and the
PPG's maximum slope consists purely of PTT, as shown in Figure 4-10.
PTT is important due to its relationship with blood pressure [51] [53] [54]. This
relationship is derived using the Moens-Korteweg equation (Equation (4.2)), which
relates PTT to the arterial wall elasticity, E [55] [56].
L _L
PTT = - (4.2)
PWV h
In Equation (4.2), L is the arterial length, PWV is the pulse wave velocity, E is the
modulus of elasticity (or Young's modulus) of the arterial wall, h is the arterial wall
thickness, p is the blood density, and r is the average arterial radius. It is assumed
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that h, p, and r remain relatively constant while E undergoes the largest variations.
E can be related to arterial wall pressure using Hughes equation (Equation (4.3)),
where E is a subject dependent elasticity parameter, a 0.017mmHg-', and P is
the arterial pressure [57]. Equation (4.3) states that a greater arterial wall pressure
leads to a greater modulus of elasticity, or a stiffer artery.
E = Eoeap (4.3)
Combining Equations (4.2) and (4.3) yields Equation (4.4), which shows a logarithmic
relationship between PTT and arterial wall pressure P. Constants A and B are
subject-dependent parameters that can be solved through calibration with cuffed
blood pressure measurements. Once the constants are determined, PTT can be used
for cuffiess blood pressure estimation.
P = A In(PTT) + B (4.4)
where
A 2
a
1 1 2L 2 pr
a Eoh
The majority of the work on PTT relates the estimated blood pressure P to diastolic
blood pressure (DBP) because the blood pulse wave transits a vessel at the end of
diastole [58] [59] [60]. Through the use of the PPG morphology such as the reflected
peak timing (reflected waves travel in vessels pressurized in the systolic state, Figure 4-
8), estimates of both systolic blood pressure (SBP) and DBP have been preliminarily
demonstrated [61] [62]. However, more clinical work is needed to determine the
relation of PTT-estimated blood pressure to DBP, SBP, and mean arterial pressure
(MAP).
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Chapter 5
The Clinical Test
The goal of the clinical test is to validate the ability of the wearable heart monitor to
measure heart rate, stroke volume (SV), and pre-ejection period (PEP). To achieve
this, reference clinical equipment and noninvasive hemodynamic maneuvers are ap-
plied on 13 test subjects. This chapter first introduces the wearable heart monitor
system. Then, the design of the clinical test is explained with the goal of achieving
the desired hemodynamic responses. The measurement results are analyzed to char-
acterize the head BCG morphology across test subjects and to assess the ability of
the device to measure heart rate, SV, and PEP.
5.1 The Clinical Prototype
The wearable clinical prototype's function is to measure the BCG, ECG, and PPG at
the ear and to send the data to a computer for visualization, recording, and analysis.
A block diagram of the system is shown in Figure 5-1.
5.1.1 The Device Hardware
The BCG accelerometer is a tri-axial MEMS accelerometer with digital output. Be-
cause the head BCG is in the range of 10mG,,, a highly sensitive and low noise
accelerometer is needed. Bosch's BMA180 accelerometer is chosen for its 14-bit reso-
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Wearable Heart Monitor
Computer Interface
Figure 5-1: The system block diagram of the wearable heart monitor with arrows
indicating the signal path.
lution and 0.69mGrms of measured noise at 10Hz bandwidth with ±2G range. Fur-
thermore, BMA180 has a configurable integrated digital low pass filter that can be
set at 10Hz.
The ECG front-end uses a low noise instrumentation amplifier (INA333) and a
12-bit SAR analog-to-digital converter (ADC) (AD7466) to amplify and digitize the
single-lead ECG from two gel electrodes. INA333 has an input noise of 0. 16ptV for
0.1Hz - 10Hz, which is sufficiently low to sense the 30[tV, of head ECG. As shown
in Figure 5-1, there is a high pass filter (0.16Hz) at the inputs to isolate DC voltages
and to remove electrode offsets. This is necessary because there is no third electrode
to equalize the circuit ground to the body.
The PPG front-end uses an LED driver (AD5398) that powers a red and an
infrared LED. To measure the light reflection, four photodetectors (PDB-C160SM)
are used in parallel. The signals from the photodetectors are amplified by a tran-
simpedance amplifier (LMV341) and are digitized using a 12-bit SAR ADC (AD7466).
The PPG front-end is designed by Eric Winokur.
The microcontroller (MSP430) continuously samples the BCG, ECG, and PPG
sensors and sends the data to the radio using an SPI interface. The microcontroller
also controls the PPG front-end to output the correct LED intensity and to correctly
bias the PPG transimpedance amplifier.
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The radio is a CC2500 2.4GHz low power wireless transceiver using the open
source SimpliciTI protocol. The radio communicates wirelessly with a USB receiver
that is attached to a computer.
The power management circuit draws power from a single 3V 220mAh lithium coin
cell battery (CR2032) and consists of a DC-DC regulator (TPS60242) and a linear
regulator (ADP150). The digital circuits are powered from the DC-DC regulator at
2.7V, and the analog circuits are powered from the linear regulator at 2.5V.
The computer interface consists of a CC2500 transceiver and a MSP430 microcon-
troller, which sends the received data to a UART-to-USB interface IC (FT232RL).
The USB IC creates a virtual COM port that can be accessed by computer software.
The computer records, plots, and filters the BCG, ECG, and PPG data in real time
using MATLAB.
The entire prototype is shown in Figure 5-2 with labeled components. The mi-
crocontroller and the radio are on the red colored daughter board, which is attached
to the main board using a header. The PPG board is attached to the main board
through an integrated flex board that is designed to bend 1800 so that the PPG LED's
and photodiodes rest on the mastoid of the wearer.
The PCB's are mechanically supported by a modified hearing aid housing manu-
factured by Taising Hearing Amplifier Ltd. The device is anchored to the ear using
the attached earbud. Two ECG electrodes are attached to the ear and neck area us-
ing 3M Red Dot AgCl gel electrodes. The PPG board is folded 180' backwards onto
the mastoid area behind the ear. All components on the side facing the wearer are
coated in parylene to ensure electrical isolation as part of clinical safety requirements.
Figure 5-3 shows the device being worn at the ear with the ECG electrodes applied
and with the PPG board on the mastoid area hidden from view.
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Figure 5-2: a) The wearable heart monitor used in the clinical test, b) the device
backside with the case removed, and c) the computer interface.
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Figure 5-3: The clinical prototype being worn at the ear.
5.1.2 The Microcontroller Firmware
The MSP430 microcontroller firmware on the wearable heart monitor serves three
functions: the initialization of all circuits, the polling of sensor data, and the trans-
mission of packetized data to the radio. The MSP430 firmware on the USB receiver
unpacketizes the received data and sends it to the USB IC, which in turn sends the
data to the computer. The firmware is written in C in Code Composer Studio v4 and
can be represented by the flowcharts in Figure 5-4.
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(a) (b)
Figure 5-4: Firmware flowcharts of a) the wearable heart monitor and b) the computer
receiver.
5.1.3 The Computer Software
The MATLAB script on the computer reads the received data from the virtual COM
port, records the data into memory, and plots the data with real time filtering. Fig-
ure 5-5 shows a flowchart of the MATLAB script.
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Figure 5-5: The MATLAB script flowchart.
Figure 5-6 shows a screenshot of the real time plots displayed by MATLAB. Plots
of red PPG, infrared PPG, filtered PPG, ECG, filtered ECG, and tri-axial accelera-
tions are displayed simultaneously for immediate feedback during the clinical test.
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Figure 5-6: A screenshot of the MATLAB real time plotter.
5.2 The Clinical Test Design
The clinical test's goal is to alter the subject's PEP and heart rate through non-
invasive hemodynamic maneuvers. The first maneuver is the head-up tilt maneuver,
where the subject lies facing up on a motorized tilt table that is tilted between
horizontal and 750 vertical. The second maneuver is the Valsalva maneuver, which
is a breath-hold exercise where the subject tries to forcibly exhale against a closed
airway. From these maneuvers, the signals measured from the device are compared
against reference measurements from commercially available equipment.
The test begins with consenting the subject and then completing a health ques-
tionnaire to ensure that the subject has no previous cardiovascular conditions. Then,
reference measurement equipment is connected to the subject. The equipment is
shown in Figure 5-7 and includes the Criticare 504-US chest ECG and finger pulse
oximeter, the Finapres Portapres for continuous blood pressure, and Sonosite BioZ
Dx impedance cardiography (ICG) machine for continuous PEP and SV. The ECG,
PPG, and Portapres data are recorded on an Agilent DSO6104A oscilloscope sam-
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pling at 500Hz in high resolution acquisition mode where the oscilloscope internally
oversamples to achieve greater resolution. The ICG data is internally recorded on the
BioZ device.
(a) (b)
(c) (d)
(e)
Figure 5-7: The measurement equipment: a) the Criticare 504-US (with transducers),
b) the Finapres Portapres, c) the Sonosite BioZ Dx ICG, d) the Agilent DSO6104A,
and e) the motorized tilt table.
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The Criticare unit measures the chest ECG in a modified Lead II configuration
with one electrode placed on the left chest (left mid-clavicle and sixth intercostal), and
the second electrode placed on the right chest (right mid-clavicle and first intercostal).
The ground ECG electrode is placed at the right mid-clavicle and sixth intercostal.
The Criticare unit also measures transmission PPG on the left index finger. The Por-
tapres unit obtains continuous blood pressure through peripheral pressure detected
at the left middle or ring finger using the volume clamp method [63]. The ICG ma-
chine obtains PEP by detecting the delay between the ECG's Q-wave and the ICG's
B-wave (Section 4.1). The ICG machine also calculates SV based on SV's depen-
dence on PEP/LVET as described in Section 4.1. Two ICG electrodes are placed
on each side of the torso (midaxillary and sixth intercostal), and two ICG electrodes
are placed on each side of the neck along the midaxillary. Lastly, the wearable heart
monitor is attached onto the subject with the PPG sensor placed on the mastoid
area above Reid's line, one ECG electrode placed below the mastoid, and one ECG
electrode placed on the upper middle neck.
The test procedure is summarized below:
1. Subject consent
2. Nurse assessment
3. Administer and review health questionnaire
4. Setup equipment and device on subject
maneuver
Portapres calibration and cuffed
nmonitor at arm) measurement
Supine (2 min) to tilted (2 min)
Portapres calibration and cuffed
Tilted (2 min) to supine (2 min)
Portapres calibration and cuffed*
Supine (2 min) to tilted (2 min)
Portapres calibration and cuffed*
Tilted (2 min) to supine (2 min)
blood pressure (automatic oscillometric
blood pressure measurement
blood pressure measurement
blood pressure measurement
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0. Tilt
5.1
5.2
5.3
5.4
5.5
5.6
5.7
5.8
6. Valsalva maneuver
6.1 Portapres calibration and cuffed blood pressure measurement
6.2 Stand at rest (40 sec), Valsalva (20 sec), then stand at rest (40 see)
6.3 Portapres calibration and cuffed blood pressure measurement
6.4 Stand at rest (40 sec), Valsalva (20 sec), then stand at rest (40 sec)
6.5 Portapres calibration and cuffed blood pressure measurement
6.6 Stand at rest (40 sec), Valsalva (20 sec), then stand at rest (40 sec)
7. Exit cuffed blood pressure measurement
8. Exit questionnaire
The setup time and the test duration are each approximately one hour. 13 healthy
subjects are tested, consisting of 10 males subjects and three female subjects. The
subjects varied from 25 to 63 years old, 1.55m to 1.93m in height and 49.9kg to 103kg
in mass. The clinical test is conducted at the MIT Catalyst Clinical Research Center
(CRC) under IRB approval #1104004449, CRC protocol #615, and grant #UL1
RR025758.
5.3 The Clinical Test Results
5.3.1 Head BCG Measurements
Table 5.1 summarizes the subject parameters and individual head BCG charac-
teristics in the standing posture, where BMI is the Body Mass Index (BMI f
mass(kg)/height(m)2 ), HR is the average heart rate obtained over a 40s time win-
dow, and RJI is the average RJ interval obtained over the same 40s time window.
Amplitudes of I, J, and K-waves are extracted from the individual ensemble aver-
ages. NSDE is the normalized standard deviation of beat-to-beat waveforms from
the ensemble average of 20 beats (Section 2.4.1). SV is measured by the BioZ ICG
machine as described in Section 5.2. All BCG signals are bandpass filtered from 1Hz
to 10Hz prior to analysis to remove gravity contribution and higher frequency arti-
facts. Figure 5-8 shows the 20-beat head BCG ensemble averages from all subjects
in the standing posture.
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Subject Age Height Mass BMI HR RJI I Amp J Amp K Amp NSDE SV
(m) (kg) (bpm) (ms) (mG) (mG) (mG) (%) (mL)
H001 27 1.78 67.1 21.2 100 159 -1.5 3.9 -2.0 41 67
H002 27 1.80 74.8 23.1 90 166 -1.6 3.4 -2.6 41 72
H003 28 1.83 81.6 24.4 95 157 -1.4 3.8 -2.6 42 83
H004 31 1.70 70.3 24.3 68 160 -0.6 3.3 -2.8 37 71.
H005 26 1.83 72.6 21.7 71 132 -0.2 4.7 -5.8 33 72
H006 40 1.93 103 27.7 70 153 -4.3 6.0 -5.6 35 122
H007 49 1.78 78.0 24.6 65 159 -3.3 5.4 -2.9 24 102
H008 53 1.75 85.3 27.9 73 187 -2.4 3.0 -1.7 47 82
H009 60 1.83 78.0 23.3 60 184 -1.4 4.5 -3.5 34 102
H010 33 1.55 49.9 20.8 67 169 -0.8 2.6 -1.7 29 60
H011 25 1.70 66.7 23.1 73 188 -2.4 2.7 -0.9 45 56
H012 54 1.83 83.9 25.1 76 143 -0.3 3.6 -2.2 43 76
H013 63 1.65 61.7 22.7 78 201 -0.5 3.1 -1.3 48 67
Mean 39.7 1.77 74.8 23.8 76 166 -1.6 3.8 -2.7 38 79
Stdev 14.2 0.097 12.9 2.2 12 20 1.2 1.0 1.5 7.1 19
Table 5.1: A summary of subject parameters and head BCG characteristics in the standing posture.
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Figure 5-8: 20-beat head BCG ensemble averages in the standing posture from a)
H001 to m) H013. The gray traces indicate the underlying individual BCG waveforms.
Several observations can be made from Table 5.1 and Figure 5-8. While there
are significant variations in the H, L, M, and N-waves, all subjects possess an IJK
wave complex in the ensemble BCG, with an average IJ amplitude of 5.4mG and an
average JK amplitude of -6.5mG. The average NSDE is 38%, which is equivalent
to meaning that at any point in time, an average subject's BCG can fluctuate with
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NSDE x JAmp = 38% x 3.8mG = 1.44mG of standard deviation from the ensemble
average.
Figure 5-9 plots measured heart rate and SV versus the RJ interval. As expected,
no correlation is observed because there is no direct physiological relationship. In
fact, the RJ interval does not show correlation to any of the other parameters in
Table 5.1.
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Figure 5-9: a) Heart rate versus the RJ interval and b) stroke volume versus the RJ
interval.
5.3.2 Heart Rate Measurements
To demonstrate the ability to extract heart rate from the head BCG, Figure 5-10
shows simultaneously extracted heart rates from the ECG and the head BCG from
27,900 heartbeats from 13 subjects in postures of standing, sitting, and supine.
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Figure 5-10: A comparison of simultaneously measured heart rates from the ECG
and the head BCG.
Table 5.2: Mean absolute error of heart rate between the ECG and the head BCG.
Posture Standing Sitting Supine
Mean absolute HR error [bpm] 0.72 1.27 0.84
With an overall mean absolute error of 0.76 beats per minute and a standard
deviation of error of 1.27 beats per minute, it is shown that the head BCG can be
used to accurately monitor heart rate in states of rest without the use of electrodes.
5.3.3 Stroke Volume Measurements
Figure 5-11 plots SV (measured by the BioZ ICG machine) versus I, J, and K-wave
amplitudes.
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Figure 5-11: a) I-wave amplitude versus stroke volume, b) J-wave amplitude versus
stroke volume, c) J-wave amplitude (with H005 and H008 removed) versus stroke
volume, and d) K-wave amplitude versus stroke volume.
J-wave shows the highest correlation with SV. This correlation exists because the
BCG recoil is directly related to the mass (or volume) of the pumped blood. Figure 5-
11(b) shows a linear fit to the origin with R 2 = 0.66. However, if outlier subjects H005
(had chest surgery to correct for pectus excavatum) and H008 (BMI is 1.9 standard
deviations higher than the average BMI of tested subjects) are removed in Figure 5-
11(c), the R 2 value improves to 0.90 for the remaining 11 subjects. An interesting
observation is that the ratio of SV to J-wave amplitude is relatively constant across
the test subjects. However, a larger scale study needs to be performed to make a
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conclusion about the general population.
The immediate value of the observed relationship between J-wave amplitude and
SV is the ability to continuously trend a subject's SV and cardiac output (CO).
This is demonstrated in Figure 5-12 where a subject performs a brief weight lifting
exercise. Here, SV is estimated by multiplying the ensemble J-wave amplitude with
20.3mL/mG (the slope from Figure 5-11(b)), and CO is estimated by multiplying
the heart rate by the estimated SV. As expected, the estimated SV and CO are
heightened due to exercise and then slowly decrease to the resting baseline. It should
be noted that during exercise, SV and CO cannot be estimated because the J-waves
are overwhelmed by motion artifacts.
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Figure 5-12: Heart rate, estimated
and after exercise for one subject.
stroke volume, and estimated cardiac output before
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5.3.4 RJ Interval and Pre-ejection Period Measurements
The RJ interval's significance lies in its correlation to the heart's PEP. For the study,
both head-up tilt and Valsalva maneuvers are designed to induce a temporary in-
crease in PEP in the subjects. The RJ interval is extracted by cross-correlating
(Section 4.1.1) the wearable heart monitor's ECG and BCG, while the reference PEP
is measured using the ICG machine.
Figure 5-13 shows a representative example of measured RJ intervals and PEP
from a subject who performs a Valsalva maneuver from 43s to 63s.
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Figure 5-13: Simultaneously measured
neuver.
RJ intervals and PEP during a Valsalva ma-
During a Valsalva's intra-thoracic strain, venous return and ventricular filling
volume are reduced. The smaller filling volume reduces cardiomyocyte stretching,
which leads to a weaker contraction and hence a prolonged PEP [47] [64]. The PEP's
increase of 30ms corresponds to an equal increase in the RJ interval during the strain.
The results in Figure 5-13 are consistent with the RJ interval trends during Valsalva
and with the PEP correlation documented in [45] and [46].
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In the head-up tilt maneuver, the subject is tilted between 0' (supine) and 750
(tilted). A representative example of simultaneously measured RJ intervals and PEP
is shown in Figure 5-14.
160
- RJ Interval
150 - PEP
140
130 -
E120 -
0 -
S100 -
90-
80 -
70 - SUPINE TILTED SUPINE TILTED
0 200 400 600 800 1,000 1,200 1,400
Time [s]
Figure 5-14: Simultaneously measured RJ intervals and PEP on a subject that is
tilted twice.
From Figure 5-14, we see that PEP increases when the body is tilted. By the
same principle of reduced cardiomyocyte stretching during Valsalva, the increase in
PEP is caused by the reduction of ventricular filling volume, this time due to venous
pooling at the lower extremities [47] [64]. Similarly, the RJ interval also increases
when the body is tilted.
In both maneuvers during the clinical test, it is observed that the RJ interval
is always longer than PEP by an offset duration that is subject dependent. This is
because the end of PEP is marked by the opening of the aortic valve, while the J-wave
occurs when the blood is accelerating after exiting the heart. This offset is affected by
variables such as body height and blood pressure, thus making it subject dependent.
Furthermore, PEP begins at the ECG's Q-wave, while the RJ interval begins at the
ECG's R-wave. The QR interval marks a delay in the electrical propagation of cellular
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depolarization. This delay is another reason why the offset between the RJ interval
and PEP is subject dependent. The relationship between PEP and the RJ interval is
illustrated in Figure 5-15.
PEP
RJ interval
1 )Time
ECG Q-wave: Aortic valve Blood max
opens accel.
(BCG J-wave)
ECG R-wave
Figure 5-15: The sequence of events from the ECG's Q-wave to the BCG's J-wave
illustrating the offset between PEP and the RJ interval.
Figure 5-16 plots the beat-to-beat RJ interval versus PEP after removing the
subject-dependent RJ interval-PEP offsets. The data consists of 28 tilt maneuvers
from seven subjects with 2,258 beats total. The remaining six subjects had faulty
PEP measurements as the BioZ ICG machine was unable to locate B-waves on certain
subjects.
As seen in Figure 5-16, the RJ interval exhibits a near one-to-one linear depen-
dence on PEP, with a slope of 0.96 and an R 2 value of 0.96. Subject 7 contains
some spread of data which is caused by measurements taken during the tilting of the
table. A Bland-Altman representation of the data is shown in Figure 5-17, where the
standard deviation in differences between the beat-to-beat RJ interval and PEP is
9.6ms for seven subjects.
This clinical data verifies that the RJ interval measured at the head can be used
to estimate PEP after removing subject-dependent timing offsets. This supports the
hypotheses in Chapter 4 and demonstrates that a portable and wearable method of
PEP measurement is possible using the head BCG and the head ECG.
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Figure 5-16: The beat-to-beat RJ interval and PEP among seven subjects during 28
tilt maneuvers.
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Figure 5-17: The Bland-Altman representation of the beat-to-beat RJ interval and
PEP from the same data set used in Figure 5-16.
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Chapter 6
A Nanowatt ECG ASIC for
Motion-tolerant Heartbeat
Detection and R-wave Timing
Extraction
This chapter presents the design and measurement results of a nanowatt electrocardio-
gram (ECG) application-specific integrated circuit (ASIC) that performs heartbeat
detection. The ECG ASIC is capable of extracting R-wave timings, which can be
used by the wearable heart monitor to determine heart intervals such as the RR
interval, the RJ interval, and pulse arrival time (PAT). Based on the knowledge of
ECG morphology at the chest and the head, a new circuit topology is implemented
to significantly reduce power consumption and circuit constraints. Each circuit block
is discussed in detail. Measured IC results from both electrical and human tests are
presented. Finally, a method to extract R-wave timings from the ASIC output is
validated using clinical data.
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6.1 The Standard Topology for ECG Heartbeat
Detection
Traditionally, the topology for an ECG heartbeat detection circuit consists of a low
noise instrumentation amplifier (IA), an anti-alias filter, an analog-to-digital converter
(ADC), and a digital signal processor (DSP) or microcontroller [65] [66] [67]. This
topology is employed in the clinical wearable heart monitor prototype and is shown
in Figure 6-1.
ECG -- 1-DSP or pCECG -- IA ADC for Heartbeat Digital OutputsElectrodes Anti-alias Detection
Figure 6-1: The standard topology of an ECG heartbeat detection circuit.
In this topology, the IA amplifies the differential ECG signal with low noise op
amps to minimize the addition of circuit noise. The gain of the IA is set so that
the amplified output is not saturated. After the anti-alias filter, the ADC uniformly
quantizes the ECG signal, treating small features such as the ECG's P wave and
large features such as the ECG's R wave with equal resolution. The ADC is usually
implemented with a medium resolution successive approximation (SAR) architecture
to minimize power consumption. Finally, to detect heartbeats, the digitized ECG is
processed by a microprocessor using a peak detection algorithm to detect R-waves.
Depending on the computational power available, such an algorithm ranges from
simple thresholding to wavelet transforms.
The traditional topology is necessary for clinical ECG measurements, where multi-
lead ECG signals are acquired with high quality in order to diagnose complex arrhyth-
mias. These recordings are usually quantized with at least 12 bits to preserve P wave
details [68]. The American Heart Association recommends a sampling frequency of at
least 150Hz to capture all features, while stating that a bandwidth of 1Hz to 30Hz
generally produces a stable ECG without artifacts [69].
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6.2 A New Topology for ECG Heartbeat Detec-
tion
For applications such as the wearable heart monitor, only the R-wave timing is rele-
vant. To take advantage of this fact, a new topology is designed to remove the need
for ADC and signal processing to significantly decrease the circuit's power and area.
At the same time, the new topology can robustly extract heartbeat timings in the
presence of motion artifacts and degraded signal quality.
The proposed topology is based on the fact that heartbeat detection relies on the
ECG's QRS complex, which has a higher frequency content and a greater magnitude
than adjacent ECG features. This circuit topology is shown in Figure 6-2 along with
an ECG illustration.
In Figure 6-2, the differential ECC signal is first amplified by a low noise pro-
grammable gain amplifier (PGA). The PGA's output splits into two paths. The first
path goes through the "QRS Amp," which has a bandwidth that preserves the QRS
complex. The second path goes through the "Baseline Amp," which has an equal
gain but a lower bandwidth to preserve only the low frequency baseline drift caused
by motion artifacts. Then, a positive inline DC offset VDc is added to VBaseline to
create an adaptive threshold VBaseline+DC. One can observe that a QRS complex (or
heartbeat) occurs whenever VQRS > VBaseline+DC. This comparison is performed by a
comparator, which consequently pulses a high DOUT when a heartbeat is detected.
To correctly set VDC, it is incremented until the period between DOUT pulses is
regular and is in the range of human beat-to-beat interval. As shown in Figure 6-2,
there is a wide range of valid VDC values since VDC can be set at any level between the
R-wave and the next highest feature (usually the T-wave). VDC is set by an external
microcontroller at the beginning of measurement and the one-time calibration takes
less than one minute. The microcontroller is powered off afterwards. If the subject's
R-waves are consistently irregular, then the calibration would be unable to complete,
which by definition can be used to imply the presence of irregular beats.
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Figure 6-2: a) The new topology for ECG heartbeat detection with voltage nodes
labeled, and b) color-matched time waveforms illustrating the QRS complex, baseline,
baseline with VDC offset, and digital output.
The above method of setting VDC can be accelerated if the R-wave voltage is
known, in which case VDC can be initially set at the midpoint between baseline and
R-wave voltage. This skips the region of VDC where VBaseline+DC is close to VBaseline
and thus DOUT is noisy and invalid. However, to process the peak R-wave voltage
information in the VDC algorithm, an ADC is needed. The power consumption of
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this ADC is unimportant because it can be turned off after calibration. Also, this
ADC can be low resolution and requires insignificant die area. Such an ADC is not
implemented in the current design because it is proposed after fabrication, but it is
a useful addition for a future iteration.
There are several advantages to this topology in terms of circuit design. First,
no signal processor or ADC is required, which significantly reduces the device power
and die area. Second, a low voltage supply is possible because a clipped R-wave that
exceeds the amplifier's dynamic range still possesses beat information. Third, any
comparator offset is automatically compensated due to the VDC calibration. Fourth,
amplifier linearity is unimportant because the signal path is highly nonlinear. In terms
of practical usage, this topology is tolerant to motion artifacts because the signal is
compared against its own baseline. Furthermore, no predefined subject-dependent
parameters are needed.
6.3 The ECG ASIC Circuit Design
The ASIC is designed in the TSMC 0.18pm CMOS technology. VDD = O-8V is
chosen as a compromise between low power and the dependence on threshold voltage
variation. This section will describe each of the circuit blocks in Figure 6-3.
Current Reference
ECG VPGA QRS VQRS
Electrodes Am
Ai DOUT
Voltage Reference
Clock Generator
Figure 6-3: The circuit blocks of the ECG ASIC.
95
6.3.1 The Programmable Gain Amplifier Design
The PGA's function is to amplify the ECG directly from the electrodes with minimal
circuit noise and power while having a range of gain to adapt to ECG's at various
locations on the body. Figure 6-4 shows the schematic of the PGA, which consists of
an op amp in the difference configuration.
Cf Bank: 20fF - 1.28pF
Reset-] R= 13T0
1 p/5p 1 p/5p:
C in = 12pF ...............
ECGAv 
VPGAElectrodes
Cin
C Bank:{1 R
Reset
Gnd VCM
Figure 6-4: The PGA schematic.
Sensing a biopotential such as the ECG creates several circuit requirements. First,
because the ECG amplitudes vary between different body locations and different
subjects by up to two orders of magnitude, an adjustable gain is required. The gain
of the PGA is set by Ci/Cf, where Ci, = 12pF and Cf is implemented as a 6-bit
binary weighted capacitor bank of 20fF to 1.28pF to adjust the PGA gain from 19dB
to 56dB. The capacitor bank is shown in Figure 6-5.
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Approximately 10fF of parasitic capacitance between A and B
20fF x32
_R GAINSEL<5> 1
20fF x16
GAIN _SEL<4>
20fF x8
GAIN SEL<3>
A 0- - B
20fF x4
GAIN SEL<2>
20fF x2
GAIN SEL<1>
20flF 20fF
GAIN SEL<0>n
Figure 6-5: The 6-bit binary weighted capacitor bank used for gain adjustment.
Second, the AgCl electrode's half-cell potential generates approximately 200mV
of near-DC electrode offset voltage (EOV) which will saturate the amplifier if not
removed. To filter this EOV, thick-oxide PMOS pseudo-resistors (R,) are used [70].
The Rp's are diode-connected PMOS transistors when VSG is positive. When VSG is
negative, the R,'s are diode-connected source-well-drain PNP bipolar junction tran-
sistors. In either case, R,'s incremental resistance is very high when the voltage across
the pseudo-resistors is low, as shown in Figure 6-6.
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Figure 6-6: Measured incremental resistance versus applied voltage of a single-
transistor R, in 1.5pm process (Figure from [70]).
In the current design, the R,'s are 13TQ but only occupy 10ptm 2 . This makes
on-die sub-Hz high pass filters feasible (fh = 1/(27rRCf) = 0.61Hz in the case of
C = 20fF), which effectively filters the EOV. For any PGA gain setting except for
the highest gain, Cf would be greater than 20fF and a smaller value of R, (such as
caused by process variations) can be tolerated while maintaining a sub-Hz high pass
corner frequency.
The third requirement on the PGA is a large input impedance. The ECG voltage
V sensed at the PGA inputs is voltage divided across Zf and R, (Zf = 0.80TQ at
20fF and 10Hz), which is in series with the electrode resistance (Reec ~ 300kQ) and
Zm (Zin = 1.3GQ at 12pF and 10Hz). This series connection is shown in Figure 6-7.
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Reiec Zin
in Z RZ
Gnd
Figure 6-7: The voltage division that occurs at the PGA input.
By having R, = 13TQ, the input impedance (Zf R,) is at least two orders of
magnitude greater than Zin + Reec, resulting in less than 1% of attenuation due to
voltage division. Furthermore, because the input impedance is significantly larger
than Reec, any differential voltage caused by unequal and varying Reec (such as
during motion) is negligible.
It should be noted that the high impedance at the PGA input nodes leads to long
start-up settling times. As a solution, reset switches shown in Figure 6-4 are added
to the PGA inputs to immediately shunt the input nodes to their final common-
mode DC voltage VCM, which is a mid-rail voltage generated by the voltage reference
(Section 6.3.5).
The PGA's op amp is a two-stage Miller-compensated op amp. This topology is
chosen because of its compatibility with low voltage supply, wide output swing, and
self-bias. Because the ECG at remote locations on the body can be as low as 30p,
the op amp needs to minimize circuit noise while consuming very low power. At the
low frequencies of ECG signals (1Hz - 25Hz), amplifier noise is dominated by 1/f
noise instead of thermal noise. In addition, the low signal bandwidth allows the op
amp to have a correspondingly low bandwidth. This means that the op amp can be
in deep subthreshold with low 9m without compromising signal quality.
Chopper modulation at the PGA inputs is a possible method to eliminate 1/f
99
noise. However, chopper switches introduce a current path between the PGA inputs.
If there is any input offset voltage, then an offset current will exist that can saturate
the PGA through the high resistance feedback R,. A solution is to use a Gm - C
servo-loop to provide a current path, but it consumes additional current and adds
complexity [71]. For this reason, chopper modulation is not used.
The PGA op amp schematic is shown in Figure 6-8.
VDD VDD
VBIAS -
Vin-n -- [-
M3
M8
Vout
M6
Gnd
Figure 6-8: The PGA two-stage op amp schematic.
The transistors are sized to minimize 1/f noise. The input-referred 1/f noise
spectral density for this op amp in subthreshold is shown in Equation (6.1) [72]:
V2 fsub 2-K 1  2.K 3
= f+Af W1L1C!,f W3L3C2,f (6.1)
According to Equation (6.1), the following design choices are made to minimize 1/f
noise:
e PMOS input transistors are used because they offer lower noise coefficients than
NMOS transistors: K1 = K, < K,.
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" Increasing W3 and L3 will reduce the noise contribution of the mirror transistors.
However, signal swing places an upper limit on W 3 and process technology places
an upper limit on L3 . A dimension of 100pm/20pm is chosen so that M3 and
M4's 1/f noise contributes to 20% of total input noise.
" Increasing W 1 and L1 will reduce the noise contribution of the input transistors.
However, excessive input transistor area will introduce significant parasitic ca-
pacitance at the drain of M2. This decreases the frequency of the second pole
and lowers the phase margin. A dimension of 864pm/1.5pm is chosen as a
compromise between noise and phase margin. L1 does not need to be as long as
L3 because PMOS transistors generate less 1/f noise: K 1 = K, < K" = K 3 . At
this dimension, M1 and M2's 1/f noise contributes to 40% of total input noise.
Additionally, by being eight times longer than the minimum length, the gate
length of 1.5pm reduces the input transistors' geometry mismatch.
The transistor dimensions are listed in Table 6.1.
Transistor W/L x fingers [pm/pm]
M1, M2 9/1.5 x 96 = 864/1.5
M3, M4 12.5/20 x 8 = 100/20
M5 2/0.5
M6 6.22/1
M7 2/1 x 80 = 160/1
M8 2/1 x 16 32/1
Table 6.1: Transistor dimensions of the PGA op amp.
M5 is used to insert finite nulling resistance to improve stability. M6 is sized to
eliminate systematic offset voltage in simulation. M7 and M8 are biased by VBias,
which is produced by the current reference (Section 6.3.5). The compensation capac-
itor Cc is a 1.9pF MIM capacitor which sets the op amp phase margin to be 550 at
the minimum gain of 19dB. Although the PGA is not unity-gain stable, no power-on
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(step VDD and step input) instability is observed in transient simulation until the
phase margin is decreased to be near 0' at the set gain.
Table 6.2 summarizes the simulated results of the PGA at VDD = 0.8V:
Parameter Simulated Result
Open loop DC gain 91dB
Open loop bandwidth 2.9Hz
Unity gain bandwidth 90kHz
Closed loop midband gain 20dB - 56dB
Closed loop bandwidth at max gain 0.52Hz - 130Hz
Phase margin at min. gain 550
CMRR at 60Hz 78dB
PSRR at 60Hz 53dB
Input-referred noise, 0.1Hz - 50Hz 0.98piVrms
Current consumption 91nA
Table 6.2: Simulated results of the PGA op amp.
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6.3.2 The QRS and Baseline Amplifier Design
4 Gnd Av VQRS
Cc = 560fF
Baseline 40fF
VPGAAm
1 p/5s 1 p/5pt
960fF
' Grd VBaseline
Cc = 15pF
Figure 6-9: The QRS Amp and the Baseline Amp.
The PGA's output is connected to the inputs of the QRS and Baseline Amps. As
previously mentioned, the function of the QRS Amp is to amplify the ECG signal
with a bandwidth that passes the QRS complex, while the Baseline Amp has the
same gain but with a lower bandwidth that only passes the baseline signal.
In Figure 6-9, both amplifiers use identical two-stage Miller-compensated op amps
in the non-inverting configuration. The only difference is in the compensation capac-
itors (Cc). The Cc and a sub-nA bias current create very low corner frequencies
while being area-efficient. For the QRS Amp, Cc = 560fF sets the low pass cor-
ner frequency at 25Hz, which passes the QRS complex. For the Baseline Amp,
Cc = 15pF sets the low pass corner frequency at 1Hz, which only passes the baseline
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drift. Pseudo-resistors are used to bias the inverting node and to create a sub-Hz high
pass characteristic, which reduces sub-Hz 1/f noise contributions from the PGA.
Both QRS and Baseline Amps have a fixed gain of 960fF/40fF = 28dB, thus
resulting in an overall gain range of 47dB to 84dB. At this overall gain range and
with VDD= 0.8V, the full dynamic range can be used to measure ECG signals on
various wearable locations on the body where the ECG ranges from 30[pV (ear) to
3mV, (chest).
The QRS and Baseline op amp schematic is shown in Figure 6-10, where Cc =
560fF for the QRS Amp, and Cc = 15pF for the Baseline Amp.
VDD VDD
VBIAS -
Vin-n --CE
M3
M8
Vout
M6
Gnd
Figure 6-10: The QRS and Baseline two-stage op amp schematic.
The transistors are sized for low power. The dimensions are listed in Table 6.3.
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Table 6.3: Transistor dimensions of the
Table 6.4 summarizes the simulated results
VDD= 0.8V:
QRS and Baseline op amp.
of the QRS and Baseline Amps at
Parameter Simulated Result
Open loop DC gain 85dB
Open loop bandwidth 51mHz
Unity gain bandwidth 990Hz
Closed loop midband gain 28dB
Closed loop bandwidth, Cc = 560f F 0.18Hz - 51Hz
Closed loop bandwidth, Cc = 15pF 0.16Hz - 1.9Hz
Phase margin at gain 850
Input-referred noise, 0.1Hz - 50Hz 8.3pVrms
Current consumption 560pA
Table 6.4: Simulated results of the QRS and Baseline op amp.
6.3.3 The VDC Generator Design
The VDC generator's function is to add VDC to VBaseline to produce an adaptive
threshold VBaseline+DC. The VDC generator schematic is shown in Figure 6-11.
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Transistor W/L x fingers [m/pm]
M1, M2 5/5 x 6 = 30/5
M3, M4 2.5/20 x 4 = 10/20
M5 2/0.5
M6 1.39/1
M7 0.5/8 x 4 = 2/8
M8 0.5/8 x 2 - 1/8
VBaseline+DC
b CVDC +
2.9pF V
Bank: Ob
155fF
Ctank
b 2.9pF
DC
CGnd Bank:
40fF - 5.1pF
VBaseline Gnd
Figure 6-11: The VDC generator schematic.
CVDD is a 4-bit binary weighted capacitor bank of 15fF to 155fF, and CGnd is a
7-bit binary weighted capacitor bank of 40fF to 5.1pF. CVDD and CGnd values are
selected during the initial VDC calibration by the microcontroller.
Non-overlapping clock phases <b and <bb are generated on-chip at 1.9kHz by the
clock generator (Section 6.3.5). The clock frequency is chosen as a compromise be-
tween low power (favors lower frequency) and low charge leakage (favors higher fre-
quency).
During clock phase <Db (Figure 6-12(a)), CVDD and CGnd are respectively reset
to VDD and ground. During the following clock phase <b (Figure 6-12(b)), CVDC is
charged to a final voltage of VDc = VDDCVDD/(CVDD + CGnd). During the following
clock phase <Db, VDc is added to VBaseline to produce VBaseline+DC, while CVDD and
CGnd are again reset. Ctank is present to reduce voltage ripples. With the selectable
ranges of CVDD and CG,,d, VDC can be adjusted from 0.29% to 79% Of VDD.
The simulated current consumption of the entire VDC generator at VDD = 0.8V
and VDC = 50mV is 2.OnA, of which 80% is used by the buffer amplifier.
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CVDD
15fF -
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VDD
CVDD
Gnd
VBaseline+DC
Ctank
CVDC {VDC
VBaseline
CGnd
Gnd
(a)
CVDC =
CVDD
=_ VDC
CLI]LI
Gnd
(b)
Figure 6-12: The VDC generator in a) clock phase <Db and b) clock phase <b.
In consideration for long term at-home usage where the ECG electrodes are applied
by the wearer, the VDC generator has the ability to generate negative VDC if the user
accidentally reverses the electrodes. This is symbolized by the two digital blocks in
Figure 6-11 that can flip CVDC during phase <bb. In the case that the ECG is reversed
and CVDC is flipped, then the heartbeat occurs when DOUT= 0 instead of DOUT 1.
These digital blocks are expanded in Figure 6-13.
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CVDC VoC . Reversed Flipb
VBot
VTop VBot
Flipb-
Cvc == VDC
Io- Flipb
VTop VBOt
Figure 6-13: CVDC can be flipped during phase <bb in case of reversed electrodes.
Because the switching frequency is only 1.9kHz and CVDC = 2.9pF, a leakage
current of only 5.5pA can reduce VDC by 1mV between clock cycles. Therefore, all
switches need to be low leakage switches to prevent capacitor discharge. To reduce
leakage, stacked switches with a feedback buffer are implemented based on [73]. The
switch schematic is shown in Figure 6-14.
Ob Ob
Ileak
VA a VB
Gnd
'leak VB
VA
VDD
Gnd
Figure 6-14: Low leakage switch implementation to prevent capacitor discharge.
The stacked switches reduce fIcak by decreasing the |VGSl of the switches. The
feedback buffer uses a self-biased source follower to drive VM to the same voltage as
VB, thus further decreasing 'leak by reducing the |VDSI of the switch closest to the
capacitor.
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6.3.4 The Comparator Design
VDD
TOU
o| M15 M16 |
-| M13 M14
-M11Ml ]M M12
Gnd
vDD
T vout-
9 M3 M4
SR Latch
vBaseline+DC -- M 1 M2 H- VQRS
Gnd
Figure 6-15: The dynamic latched comparator with SR latch.
The comparator's role is to output a digital "1" (or a digital "0" if the electrodes are
reversed) when a QRS complex has occurred, which is when VQRS > VBaseline+DC.
A dynamic latched comparator based on [74] is used (Figure 6-15). The dynamic
topology is chosen because it consumes power only when latching. This topology
offers the additional benefit of only using a single clock signal 4, thus placing no
requirements on (Db timing.
In Figure 6-15, when clock D is low, VL and VR are precharged to VDD and all nodes
of the cross-coupled inverter pair are discharged to ground. When clock 4 transitions
from low to high, VL and VR begin to discharge through M1 and M2 to ground. If
VQRS > VBaseline+DC, then VR will discharge faster than VL. Consequently, M12 and
M14 will turn off sooner than M11 and M13, and M16 will turn on sooner than M15.
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As a result, the source terminal of M8 will reach VDD sooner than M7, thus raising
Vst_, faster than VOst,?. The positive feedback amplifies this difference, causing the
outputs to latch to a high V 0st_, and a low Vet,. Conversely, if VQRS < Vaseline+DC,
then Vt_, will be low and Vst, will be high.
M11 and M12 are added to reduce short circuit currents through M13 to M16
when VL and VR are transitioning. This is important because the short circuit currents
can be several nano-amps. VBaseline+DC contains switching transients from the VDC
generator. However, these transients are designed to occur with <b, which do not
affect comparator accuracy because comparator latching occurs with <D.
M1-M4 gate lengths are set at 1[tm to reduce geometry mismatch. A Monte Carlo
mismatch simulation of 100 runs produces an input-referred comparator offset range
of -13mV to 16mV. However, as mentioned in Section 6.2, no comparator offset
compensation is needed due to the VDC calibration routine. The final output of the
SR latch, DOUT, is a digital signal that pulses when a heartbeat is detected.
The comparator's transistor dimensions are summarized in Table 6.5. The com-
parator's simulated current consumption at VDD= 0.8V with a clock frequency of
1.9kHz is 0.38nA.
Transistor IIW/L x fingers [pm/pm]
M1, M2 1/1 x 4 = 4/1
M3, M4 2/1 x 4 = 8/1
M5, M6 1/0.5
M7, M8 2/0.5
M9-M16 1/2
Table 6.5: Transistor dimensions of the comparator.
6.3.5 Peripheral Circuits
The ECG ASIC requires no off-chip active and passive components because all the
peripheral circuits are on-chip. The peripheral circuits are designed to use less than
10% of the overall power consumption.
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Current Reference
The current reference biases the currents of the PGA, QRS Amp, Baseline Amp, all
buffer amplifiers, and clock generator. The current reference is based on the fast
startup current reference in [75], which uses a startup circuit that consumes no static
current. The schematic of the current reference is shown in Figure 6-16.
VDD
NT
Ctop Cstart Cdec
950fF 110fF 950fF
M3 |l M4 M9 M10
VBIASJp VRO-P
IREF M5 Vstart
VBIASn I - VRO n
M1 M2 M6 M8
VBIAS n
RBIAS Cbot | 7IA E- M  Cdec
5.6Mfl 950fF 950fF
Gnd
Figure 6-16: The current reference.
Transistors M1 to M4, along with RBIAS, form the classic current reference where
IREF ( Vthermal/RBIAS)l n (WkI1/WM2). RBIAS is a high resistance poly resistor
implemented on chip. With a designed ratio of WMi/WM2= 9/8, the IREF is set to
0.55nA. The voltage VBrASp is distributed to all amplifiers to bias the tail current
sources.
To avoid a startup state of IREF = 0, the components in gray in Figure 6-16
comprise the startup circuit. The instant that VDD is switched on, VBIASp is at VDD
because of Ctop, VBIAS-n is at ground because of Cbot, and Vstart is at VDD because
of Ctart. This state turns on M5, which shorts VBrAs_p and VBIASn. In this instant,
VBIASp = VBIAS-n = VDD/ 2 , which turns on M2 and M4 and the circuit is started.
Meanwhile, M6 is on and discharges Vatart to ground, thus turning off M5 and shutting
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off the startup circuit. Ctop and Cbot remain as decoupling capacitors.
VBIAS-n is routed to M7-M1O to create bias voltages VROp and VROn for biasing
the starved ring oscillator in the clock generator.
The current reference's transistor dimensions are summarized in Table 6.6. The
current reference's simulated current consumption at VDD = 0.8V is 2.8nA.
Transistor W/L x fingers [pm/pm]
M1 1/1 x 9 = 9/1
M2 1/1 x 8 = 8/1
M3, M4 2/1
M5, M6 4/0.5
M7 1/1 x 2 = 2/1
M8 1/1
M9, M10 2/1
Table 6.6: Transistor dimensions of the current reference.
Voltage Reference
The function of the voltage reference is to generate VcM = VDD/ 2 for the common-
mode voltage of the PGA. Absolute VcM accuracy and temperature independence are
not necessary. Therefore, a simple transistor diode ladder is used to generate VcM
as shown in Figure 6-17. All transistors are PMOS (20ptm/lpm) with body tied to
source to avoid body effect. The voltage reference current consumption (including
buffer) is simulated to be 2.8nA. The simulated integrated noise is 21tV, from 1Hz
to 100kHz. A Monte Carlo simulation of 100 runs results in a Vcm standard deviation
of 0.7mV.
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VDD
I VCM
Gnd
Figure 6-17: The voltage reference.
Clock Generator
The clock generator in Figure 6-18 provides the non-overlapping clock signals for
the VDC generator and the comparator. The clock is generated by a five-stage ring
oscillator, which uses current-starved inverters biased by VROp and VRO a from the
current reference. The 30fF capacitive loads ensure that a rail-to-rail oscillation is
achieved.
Following the ring oscillator is a four-stage starved inverter chain of increasing
currents. This chain is crucial in reducing the short-circuit current in the subsequent
non-starved inverters, which can be as high as tens of nano-amps. After a three-stage
non-starved inverter chain, a non-overlapping clock generator is used to produce clock
signals 4 and 4 b. Non-overlapping clocks are required for the switched-capacitor VDC
generator. The clock generator's simulated current consumption at VDD 0.8V and
a clock frequency of 2kHz is 2.OnA.
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VDD
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2p/1p
In Out
Gnd
Ob
Non-overlapping Clock Generator
Figure 6-18: The clock generator.
Configuration Registers
The configuration registers load 77 bits of configuration settings into the ASIC using
shift registers. The shift registers are modified to be able to serially read out internal
bits for verification. The configuration settings include:
" PGA gain settings (6 bits)
" PGA bandwidth and power settings (10 bits)
" QRS Amp bandwidth and power settings (14 bits)
e Baseline Amp bandwidth and power settings (14 bits)
" CGnd settings (7 bits)
" CVDD settings (4 bits)
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o Reverse VDc (1 bit)
" Current reference settings (15 bits)
" Voltage reference settings (3 bits)
" Clock frequency settings (3 bits)
6.3.6 Physical Layout Considerations
Device matching of the analog circuits is crucial because all devices operate in sub-
threshold and high CMRR is required to reject common-mode interferers. To improve
matching, common-centroid layout with edge dummies is used for all amplifiers. To
avoid geometry-dependent variations, ratioed transistors used in the current mirrors
and ratioed capacitors use the same unit geometries and are scaled via multiples. All
analog circuits are isolated using dual guard rings. All digital circuits are also isolated
by dual guard rings and are placed apart from the analog circuits. An example is
shown in Figure 6-19, where the PGA layout shows common-centroid layout of input
and mirror transistors, multiples of current mirror transistors (ratioed to the current
reference), and dual guard rings.
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N-well and P-well
Guard Rings
320x 2p/1 i
Mirror Transistors
200x 9p/1 .5p
Input Transistors
Figure 6-19: The physical layout of the PGA showing the common-centroid input
transistors (denoted as A for M1, B for M2, and D for dummy), the ratioed current
mirror transistors, and the dual guard rings.
6.4 The ECG ASIC Measurement Results
The ASIC is fabricated using the TSMC 0.18pm CMOS technology. The die area is
1.8mm x 1.8mm with an active area of 0.76mm 2 as shown in Figure 6-20.
The die is packaged in a 9mm x 9mm QFN-64 chip for bench testing where VDD's
are isolated and all internal blocks can be probed (Figure 6-21(a)). The die is also
packaged in a 3mm x 3mm QFN-16 chip for mounting onto the existing wearable
platform for wireless and mobile measurements (Figure 6-21(b)).
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Figure 6-21: a) The bench-level PCB with the QFN-64 ASIC in socket, and b) the
wearable PCB with the QFN-16 ASIC. The figures are to scale.
6.4.1 The Amplifier Gain and Noise Response
The ECG's amplification path goes through the PGA and then the QRS Amp. Fig-
ure 6-22 shows the gain response and input-referred noise response at the highest gain
setting. In the gain response, the plot shows the sub-Hz high pass corner enabled by
the PGA and QRS Amp's pseudo-resistors, the low pass corner implemented by the
QRS Amp's low gm and large compensation capacitor, and the 40dB/dec fall off at
higher frequencies due to the two poles from the PGA and the QRS Amp. In terms of
noise response, the circuit exhibits a 1/f characteristic below 10Hz (or 1/v/f when
using V/vIHz as unit). The noise below 0.5Hz is filtered by two sub-Hz high pass
corners from the PGA and the QRS Amp's pseudo-resistors.
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Figure 6-22: The PGA-QRS Amp signal path's gain response and noise response
measured using an Agilent 35670A Dynamic Signal Analyzer.
Table 6.7 shows the simulated and measured results from the PGA-QRS Amp
signal path.
Parameter Simulated Measured
Programmable gain range 47dB - 84dB 47dB - 88dB
Passband 0.52Hz - 51Hz 0.5Hz - 22Hz
Unity-gain bandwidth 6.4kHz 2.9kHz
Input-referred noise (in band) 0.99piVrms 2.7tVrms
CMRR 78dB 66dB
PSRR 53dB 61dB
Current consumption (at 0.8V) 92nA 64nA
Table 6.7: Measured results from the PGA-QRS Amp signal path.
Increasing the transistor bias currents did not appreciably decrease the input-
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referred noise, which indicates that the in-band noise is 1/f dominated as Figure 6-22
indicates. The measured input-referred noise is greater than the simulated noise by
2.7 times, which is likely attributed to differences between the transistor model's and
the production's 1/f characteristics. The measured level of noise is compatible with
sensing the ECG at the head, where the QRS amplitude is approximately 30jp,.
A widely used figure of merit for amplifier power-noise performance is the Noise
Efficiency Factor (NEF) proposed in [76].
NEF =Vnirms 2Itota (6.2)
nm VthermalAkTBW
In Equation (6.2), Vnirms is the input-referred RMS noise voltage, Ittal is the total
amplifier supply current, and BW is the amplifier bandwidth in Hertz. The NEF
for the PGA-QRS Amp circuit blocks is 5.7. Figure 6-23 compares the ECG ASIC's
amplifier performance with published biopotential front-end amplifiers, where it is
the lowest powered amplifier with an NEF of less than 10.
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Figure 6-23: A comparison of the PGA-QRS Amp's NEF with published biopotential
amplifiers. The data is adapted from [70] and [77].
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6.4.2 ECG Measurements
Figures 6-24 to 6-27 show measured ECG and digital outputs from various wearable
ECG scenarios to demonstrate the ASIC's robustness in the presence of baseline drift,
muscle artifacts, and attenuated signal.
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Figure 6-24: Chest ECG at rest (gain 52dB).
In Figure 6-24, the at-rest chest ECG offers 1.8mV, of stable signal. Here, VDc
is set to 0.3V so that VBaseline+DC is approximately half of the VQRs amplitude.
However, any VDc setting between 0. 1V and 0.65V would produce the correct digital
QRS output at DOUT.
In Figure 6-25, the chest ECG contains significant baseline drift due to motion.
Despite the baseline drift, the same VDc setting as in Figure 6-24 results in a cor-
rect DOUT. In fact, any VDC setting between 0.1V - 0.5V would be valid. This
demonstrates the ASIC's tolerance to motion artifacts because its adaptive threshold
VBaseline+DC tracks the baseline drift.
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Figure 6-25: Chest ECG with baseline drift due to motion (gain 52dB).
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Figure 6-26: Chest ECG with muscle artifacts and signal clipping (gain = 64dB).
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In Figure 6-26, pectoral muscle artifacts are present from a rapid horizontal 90'
arm movement. Also, the higher gain of 64dB increases the amplified ECG to 2.8V
which is beyond VDD = 0.8V and is clipped. To produce the correct DOUT, VDC needs
to be increased to 0.5V so that VBaseline+DC rises above VQRS'S muscle artifacts and
heightened T-waves. The QRS complex's clipping does not matter because the beat
information is still present. From this scenario, it can be seen that as the measure-
ment condition changes, new VDC settings are required. The need to recalibrate VDC
can be detected in real time when DOUT exceeds human heart rate range or when
DoUT becomes irregularly spaced. Once detected, the calibration routine described
in Section 6.2 can be rerun to update VDC.
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Figure 6-27: Ear-neck ECG with high gain and low SNR (gain 84dB).
In Figure 6-27, the ECG is measured across the ear and the middle upper neck.
This remote ECG vector is used in the wearable heart monitor. The gain is increased
to 84dB to sense the 30-tp, of ear ECG. At this high gain, a significant portion of the
amplified output is noise and QRS clipping is present. However, with the identical
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VDC setting as in Figures 6-24 and 6-25, VBaseline+DC is able to rise above the noise
and correctly capture the QRS complexes as shown by DOUT.
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Figure 6-28: Ear-neck ECG at VDD 1.8V and gain = 84dB during a) rest, and b)
moderate head motion.
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Because the attenuated ECG near the ear requires high gain, it is very sensitive
to motion. In this scenario, a higher VDD is beneficial to provide a wider dynamic
range. Figure 6-28(a) shows a 190s measurement of the head ECG at VDD = 1.8V
using the same lead as in Figure 6-27. Among the total number of 255 heartbeats, the
ASIC misses 11 beats (sensitivity of 95.7%) and erroneously captures 4 extra beats
(positive predictive value of of 98.5%). However, when there is moderate head motion
in Figure 6-28(b), the motion artifacts overwhelm the QRS complexes and the ASIC
is unable to reliably extract heartbeats.
6.4.3 Power Measurements
The power consumptions of the circuit blocks are measured using a Keithley 2400
SourceMeter with an averaging filter of 100 samples. Table 6.8 lists the power con-
sumption of each circuit block at VDD = 0.8V. 87% of total power is allocated to
the PGA due to bandwidth and thermal noise considerations. The peripheral circuits
consume 8.6% of the total power.
Circuit block Simulated Power (nW) Measured Power (nW)
PGA 72.8 50.4
QRS Amp 0.5 0.7
Baseline Amp 0.5 0.7
VDC generator 1.6 0.8
Comparator 0.3 0.4
Current reference 2.2 1.8
Voltage reference 2.2 1.0
Clock generator 2.0 2.2
Total 82.0 58.0
Table 6.8: Power breakdown of each circuit block at VDD 0-8V-
The ECG ASIC's elimination of ADC and signal processor enables it to reduce
power consumption and to occupy a smaller die area. Another portion of the power
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saving is contributed by the PGA's low bandwidth and simple architecture, which is
single-ended and does not use chopper modulation nor DC servo loops for biasing. A
further source of power saving is the ECG ASIC's low VDD, which is enabled by its
tolerance to signal clipping.
The ECG ASIC has sufficiently low energy consumption for one year of continuous
operation from a 0.7mAh thin-film battery, making it ideal for miniaturized and
long term heart monitoring. Besides being suitable for the presented wearable heart
monitor, the ECG ASIC is useful for battery-constrained ECG applications such
as implantable pacemakers and defibrillators. Furthermore, the ECG ASIC's power
consumption is in range of energy harvesting power sources, thus making batteryless
heart monitors a possibility.
6.5 Recovering the ECG R-wave Timing from DOUT
Accurate ECG R-wave timing is necessary for the calculations of pre-ejection period
(PEP) and pulse arrival time (PAT) for cuffless blood pressure estimation, and for
the calculation of the RR interval for heart rate variability (HRV) analysis. Although
the R-wave is clipped and its peak is lost in the eventual digital output DOUT, this
section shows that the original R-wave timing can be recovered with minimal error.
As shown by Figure 6-29, the R-wave timing can be estimated from the midpoint
timing of DOUT pulses. This method is tested on normal chest ECG records from ten
subjects totaling 2,304 heartbeats. Subjects 1 to 5 are from the MIT-BIH PhysioNet
database, and Subjects 6 to 10 are from the MIT clinical test (Chapter 5). Estimated
R-wave timings are compared with manually annotated timings. A sample result
segment is shown in Figure 6-30. The results for all ten subjects are summarized in
Table 6.9.
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Figure 6-29: Estimation of the R-wave timing using the midpoint timing of DOUT.
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Figure 6-30: Estimation of R-wave timings on a sample ECG segment from PhysioNet
database.
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Subject Number Mean R-wave Stdev. R-wave Sampling
of Beats Timing Error Timing Error Freq. [Hz]
[ims] [ims]
1 250 0.91 1.6 250
2 183 0.91 1.6 250
3 63 0.97 2.2 250
4 123 -1.70 1.6 250
5 73 -2.40 1.8 250
6 467 -1.50 0.71 500
7 363 -1.00 0.71 500
8 357 -2.80 0.72 500
9 226 -0.88 0.72 500
10 199 -0.29 0.84 500
Overall 2,304 -0.70 1.25 -
Table 6.9: Comparison between midpoint-estimated R-wave timings and manually
annotated R-wave timings from ten subjects.
The mean R-wave timing error arises from the fact that the QR slope may be
different from the RS slope, thus resulting in the R-wave not being exactly at the
midpoint. Nine out of ten subjects' mean R-wave timing error is within the sampling
period (4ms and 2ms). In six out of ten subjects, the estimation is accurate to
within lms of the actual R-wave timing. The standard deviation of R-wave timing
error is mainly due to time quantization caused by sampling. As expected, when
the sampling frequency is doubled for subjects 6 to 10, the standard deviation of
R-wave timing error approximately halves. In nine out of ten subjects, the standard
deviation of R-wave timing error is less than half of the sampling period. In summary,
the R-wave midpoint estimation method is an accurate way to recover the ECG
peak timing information from DOUT. This enables the use of the ECG ASIC for
applications beyond heartbeat detection, such as cuffless blood pressure estimation
and HRV analysis, both of which require accurate R-wave timings.
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Chapter 7
Conclusion
7.1 Summary of Contributions
In summary, this work presents a wearable heart monitor that uses the head ballis-
tocardiogram (BCG) and the head electrocardiogram (ECG) to extract heart rate,
stroke volume, respiratory rate, and pre-ejection period (PEP).
The ear is demonstrated as a viable location for the integrated sensing of physio-
logical signals. Physiologically, the ear location is shown to provide BCG, ECG, and
photoplethysmogram (PPG) signals. Mechanically, the ear provides a discreet and
natural anchoring point that reduces the need for adhesives.
Periodic head movements are identified as a type of BCG. Two methods of measur-
ing the head BCG are implemented. The accelerometer method allows the portable
measurements of the BCG without the use of electrodes. Using ensemble averaging,
the morphology of the head BCG is shown to closely represent the traditional BCG
waveform. One direct application of the head BCG is electrode-less heart rate mon-
itoring. Another application is the estimation of stroke volume based on the BCG
amplitude.
This work also demonstrates the ability to measure the ECG near the ear. Using
both BCG and ECG signals, an electromechanical timing duration called the RJ
interval can be obtained. From heart timings, the RJ interval is shown to correlate
to PEP. Because both head BCG and ECG have low signal quality, cross-correlation
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is used to statistically extract the RJ interval without the use of peak detection.
A clinical prototype is developed that allows the portable measurements of the
BCG and the ECG at the ear while wirelessly transmitting the data to a computer.
A clinical test involving hemodynamic maneuvers is performed on 13 subjects. The
test results demonstrate a linear relationship between J-wave amplitude and stroke
volume across subjects. Also, the RJ intervals extracted from the head BCG and the
head ECG are shown to be linearly proportional to PEP across subjects.
A 58nW ECG application-specific integrated circuit (ASIC) for long term heart
monitoring is implemented. A new topology is presented that takes advantage of
the ECG's characteristics to extract heartbeat timings in the presence of motion and
muscle artifacts, signal clipping, and ECG signals as low as 30puV. The extracted
timings can be used for heart rate, RJ interval, and pulse arrival time (PAT) calcula-
tions. With the goal of reducing battery size and consequently overall device size, the
circuit's power consumption and area are aggressively reduced due to the elimination
of traditional circuit blocks and due to low power circuit design.
7.2 Future Work
As of writing, the PPG component of the system is currently being converted to an
integrated solution by Eric Winokur at MIT. This will reduce both overall device size
and total power consumption.
Further validation of the relationship between pulse transit time (PTT) and blood
pressure is needed. This is best performed in a controlled setting where a gold stan-
dard measurement of blood pressure is available, such as in a hospital on patients
with arterial lines. Long test durations are necessary to determine the frequency of
calibration needed for accurate blood pressure estimates.
Additional validation of the relationship between J-wave amplitude and stroke
volume needs to be performed. The problem with the clinical test in this thesis work
is that the heiodynamic maneuvers mechanically affect J-wave amplitude. For ex-
ample, a supine posture dampens the J-wave amplitude due to friction, thus masking
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any physiological effects due to changed stroke volume. As a result, only the standing
posture is analyzed in the current work.
In its present implementation, the system sends continuous real time data wire-
lessly to the PC for analysis. A future implementation will perform the analysis on
the microcontroller and periodically send scalar data such as heart rate and heart
intervals to the PC. This will significantly reduce the radio's duty cycle and average
power consumption. As of writing, work is currently underway to port the MATLAB
algorithms to the MSP430 in an energy efficient manner. This work is being done by
Xianzhen Zhu at MIT.
At time of writing, work is also being done to change the radio from a propri-
etary 2.4GHz protocol to the Bluetooth 4.0 Low Energy (BLE) protocol. Compared
to the current radio, BLE allows larger data packets and bandwidth, lower power
consumption, and interoperability with mobile devices. This work is being done by
Lyne Tchapmi at MIT.
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